Personalized Medicine

IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.

Volta Labs develops automated sample preparation solutions for genomic and sequencing workflows. The company's platform enables walk-away sample prep for a wide variety of sample types and is compatible across multiple NGS and long-read sequencing technologies. Their system focuses on operational efficiency, robust performance, and high-quality output for DNA/RNA extraction, library preparation, and target enrichment.

Nuclera develops automated benchtop platforms and integrated systems for rapid protein expression, optimization, and purification, utilizing cell-free synthesis, digital microfluidics, and software-driven workflows. Their technology enables miniaturized and scalable protein prototyping—including challenging targets such as membrane proteins—directly at the lab bench. Nuclera serves academic and industrial researchers, focusing on reducing turnaround time for functional protein access and streamlining screening and production. The company has secured significant funding to enable broad commercialization, expanded their leadership team to support scale-up, and continues to drive advancements in drug discovery, proteomics, and experimental automation.

Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.

Aware Custom Biometric Wearables, is a leading innovator in cutting-edge in-ear technology, specializing in superior custom hearing protection solutions and biometric hearables. Our groundbreaking in-ear solutions feature enhanced hearing capabilities, continuous monitoring, and the collection of medical-grade biometric data, all designed to enhance human performance and safeguard lives. Our commitment to innovation is reflected in our meticulously crafted in-ear devices. Thanks to our patented 3D Ear Scanner technology, we provide a custom fit tailored to the unique shape of each individual's ear which optimizes the performance of sensors. Aware is transforming the ear into a dynamic platform for health and human performance by collecting medical-grade data, delivering actionable AI-driven insights, and enabling precision therapeutics within devices we wear in our everyday lives. Our technology serves a diverse range of sectors within healthcare, military, and industrial. Proudly U.S.-based, offices in Atlanta, GA and San Diego, CA. www.AwareCBW.com.

Maverick Labs is a U.S.-based biotechnology and materials science company specializing in advanced protein design, synthetic biology, and microbial engineering. The company operates through three tightly integrated subsidiaries—Maverick Metals, Maverick Energy, and the Maverick Bio-Gene Therapy Translational Unit—each of which applies a shared technological foundation to tackle critical challenges across national defense, energy independence, and strategic material access. Together, they develop scalable, field-ready solutions that reinforce the United States’ industrial resilience and military readiness through biotechnology-driven innovation.

CRI Genetics, part of the Cellular Research Institute, aims to unlock complex genetic information and present it in an engaging and useful manner. Their mission is to enhance human life and advance the understanding of the human genome through consumer genetic reports and active participation in scientific research. They believe genetic analysis is the future of medicine and are committed to solving complex medical problems. The company ensures the privacy and security of customer data, offering an 8-week efficiency guarantee for delivering genetic reports.

Pulsara is a purpose-driven healthcare technology company focused on improving the lives of patients and caregivers through innovative, real-time communication and collaboration. Their telehealth platform connects clinicians, EMS, hospitals, and emergency management teams on a single patient channel, enabling dynamic, scalable, and secure care coordination for any illness or injury. Pulsara's evidence-based solutions are designed to reduce treatment times, lower costs, and enhance experiences for both patients and providers. The company is recognized for its customer-first values, award-winning support, and commitment to privacy, security, and interoperability.

The Precision Vaccines Program (PVP), based in the Department of Pediatrics at Boston Children’s Hospital, is an academic research initiative dedicated to discovering and developing next-generation vaccines tailored to vulnerable populations. PVP conducts both basic and translational research to create novel vaccines and therapeutics for diseases that disproportionately affect infants, older adults, and immunocompromised individuals. The program brings together experts in vaccinology, clinical trials, immunology, molecular biology, data management, biostatistics, bioinformatics, and systems biology, fostering international collaboration among academia, government, and industry to advance precision medicine in vaccinology.

Seek Labs is a biotechnology company headquartered in Salt Lake City, Utah, dedicated to advancing scientific discovery and delivering universal healthcare solutions. The company specializes in next-generation point-of-care molecular diagnostics and programmable CRISPR-based therapeutics, aiming to bridge the gap between disease outbreak and intervention. Powered by its proprietary AI discovery engine, BioSeeker™, Seek Labs is building a modular, full-stack system that enables rapid response to emerging pathogens, scalable precision treatments, and accessible diagnostics. The company is committed to global health innovation, sustainability, and community engagement, and is a proud member of Utah's BioHive life sciences ecosystem. Seek Labs' mission is to empower individuals with healthcare solutions tailored to their specific needs, revolutionizing the detection and treatment of diseases for both human and animal health.

BioPharma Connections is an independent, woman-owned consulting firm founded in San Francisco in 2007, providing strategic business development, technical operations, regulatory, product development, and commercialization support to the life sciences industry. Serving pharmaceutical, biotechnology, medical device, and diagnostic companies globally, the firm specializes in facilitating connections between organizations, service providers, CROs, CDMOs, and investors—guiding clients from concept to commercialization, with deep expertise in regulatory compliance, emerging technologies, and diverse therapeutic areas.

Xtory is a Harvard spin-off that combines AI and 3D technology to revolutionize healthcare and education. The company aims to provide trustworthy medical information and decision-making tools to improve patient outcomes and streamline clinical workflows. With a focus on innovation and scientific rigor, Xtory is dedicated to reshaping healthcare through AI-driven solutions.

cosinuss° is a medical technology company based in Munich, Germany, that is pioneering an ultralight monitoring solution in Europe for situations and use cases where the currently available monitoring solutions fail. The company specializes in in-ear biosensor technology connected to mobile devices for local application, and/or additional cloud-based analytics, supporting real-time local and remote patient monitoring for medical care in challenging operations, in remote environments, clinical trials, remote patient monitoring, and telemedicine. The solution is currently only available for sale in Europe.

Vindhya Data Science is a women-owned small business headquartered in North Carolina, USA, with a presence in RTP and Boston. We specialize in bioinformatics, genomics, artificial intelligence, and data engineering, cheminformatics, evidence-based medicine, epidemiology and related disciplines. Vindhya partners with federal government agencies, leading academic medical centers, and pharma/biotech organizations to transform large datasets into informed decisions using advanced data science technologies. With over 100 years of combined experience, 150+ publications, and 73+ successful projects, Vindhya is committed to delivering impactful solutions in the life sciences sector.

Auspex Medix focuses on developing AI-driven medical technologies aimed at improving patient outcomes and supporting healthcare professionals. Their solutions are designed to be secure, interoperable, and adaptable across various medical specialties, emphasizing evidence-based decision support and human-in-the-loop workflows.

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.

Booz Allen Hamilton is a leading management and technology consulting firm with over 110 years of experience. The company is dedicated to empowering people to change the world through innovative solutions in various sectors including cybersecurity, artificial intelligence, engineering, and defense. Booz Allen partners with government and commercial clients to tackle their most complex challenges, leveraging a culture of innovation and a commitment to excellence. The firm operates with core values of integrity, courage, service, ingenuity, and a commitment to diversity and inclusion.

PinMed, Inc., is a National Innovation Award-winning bioinformatics/medical-device company that develops high-fidelity cardiovascular monitoring systems, personalized (adaptive) software, and integrated systems and custom solutions for tracking cardiovascular data in the most challenging environments (e.g., intensive activity, extreme electromagnetic interference, and interventional cardiovascular procedures) and identifying subtle but clinically important indicators of cardiovascular events. PinMed’s award-winning solutions include versatile, multisensor, high-fidelity monitoring systems for various hospital and ambulatory settings. The company has extensive experience in electronic and mechanical engineering, development of software and firmware for various processors, computational modeling, and cardiovascular physiology. PinMed’s flagship mobile platform, PELEX, provides unparalleled versatility in physiological monitoring and has been cleared by the FDA for diagnostic 12-lead ECG testing and various types of ambulatory monitoring.

Cooper University Health Care is a regional academic health system recognized for comprehensive clinical services, advanced multidisciplinary care, specialized surgery, and robust research in South Jersey. It provides integrated healthcare across general and specialty domains, including cancer, neurosciences, cardiology, trauma, genetics, addiction medicine, and complex surgical procedures, supported by leading technologies and a network of modern facilities.

DLH delivers improved health and national security readiness solutions for federal programs through science research and development, systems engineering and integration, and digital transformation. With over 3,200 employees, DLH is committed to solving complex problems faced by civilian and military customers, leveraging advanced technologies and methodologies to enhance health outcomes and operational readiness.

Sunflower Therapeutics is a women-owned and led biotechnology public benefit corporation founded in 2018, dedicated to democratizing access to protein manufacturing worldwide. The company develops next-generation, automated, and fully-integrated protein manufacturing solutions that simplify the process from discovery to full-scale biomanufacturing. Their mission is to make high-quality, cost-effective therapeutics, vaccines, and protein-based products accessible globally, especially in low- and middle-income countries, by leveraging innovative technologies, sustainable practices, and intuitive equipment. Sunflower’s vision is to transform the global health landscape by enabling more medicines and protein products to reach patients and consumers everywhere. Their core technologies include efficient microbial hosts, data-driven process development, and modular manufacturing facilities, supporting agile, rapid, and cost-effective production cycles for a wide range of protein-based products.

Baylor University is a preeminent Christian research university committed to addressing the world's most meaningful challenges through top-tier research and scholarship. Recognized as an R1 research institution, Baylor focuses on infusing its distinct Christian mission into its research initiatives, fostering a commitment to excellence and innovation.

TIMSER S.A.P.I. de C.V. is a biomedical company in Mexico developing accessible and non-invasive blood-based screening solutions for early detection of cervical cancer and its precursor lesions. The company leverages more than a decade of research to advance clinically validated molecular diagnostics using protein biomarkers identified through proteomics and molecular biology approaches. These technologies address barriers to traditional screening and are backed by extensive national and international patent coverage and clinical trial validation involving hundreds of participants.

Entropia Labs focuses on advancing functional medicine and wellness therapeutics through AI-driven molecular design and delivery technologies. The company aims to close the gap between promising treatments and rigorous scientific validation, with an emphasis on health-span extension.

NEXT Labs is pioneering the automation and accessibility of next-generation sequencing (NGS) by developing affordable, portable solutions for sample and library preparation. Their mission is to enable sequencing anywhere, by anyone, moving NGS from specialized labs to point-of-need applications. By automating complex sample processing steps, NEXT Labs aims to democratize genomics research and diagnostics, making advanced testing faster, more accessible, and cost-effective for a wide range of applications including infectious disease detection, cancer, and neurodegenerative disease diagnostics.

Senseye is pioneering a breakthrough diagnostic platform for mental health, focusing initially on PTSD. The company aims to empower clinicians with fast, accurate tools to personalize care by establishing clear baselines and tracking outcomes over time. Senseye's innovative approach leverages brain-based diagnostics and computer vision technology to transform the diagnostic process for PTSD, anxiety, depression, and addiction into an objective process. Their platform operates on everyday smartphones, making it accessible and efficient, without the need for specialized equipment.

Ease Healthcare (a registered DBA of MPS Medical, Inc.) is committed to advancing next-generation military medicine by accelerating access to clinically validated diagnostic tools, monitoring devices, and health and wellness technologies. As a trusted commercialization partner and distributor, the company empowers providers, organizations, and individuals with advanced solutions that support early detection, timely intervention, and improved health outcomes in both civilian and military settings. With a mission to make cutting-edge science and technology accessible to all, Ease Healthcare focuses on addressing critical health challenges such as 02 delivery, cancer, and cardiovascular disease —areas that directly impact force readiness and resilience. The company’s vision is to break barriers in healthcare by delivering innovative medical solutions that are affordable, accessible, and simple to use, regardless of economic or geographic limitations. In addition to bringing transformative technologies to market, Ease Healthcare provides turnkey services for medical device manufacturing and distribution, guiding partners from product development through regulatory compliance and successful deployment. By combining technical expertise with a dedication to accessibility, Ease Healthcare supports the Department of Defense’s priorities in preparing and protecting service members with next-generation healthcare solutions.

Exponent is a multidisciplinary science and engineering consulting firm serving sectors including healthcare, energy, manufacturing, and consumer products. From medical devices, pharmaceuticals, and supplements to digital health and wearables, we deliver rigorous science that quantifies impacts on human health. Exponent helps you push the envelope on the development, deployment, safety, and effectiveness of cutting-edge drugs, devices, and diagnostics — concomitantly balancing benefits and risks. Count on our multidisciplinary, data-driven, evidence-based assessments to give you clarity on your most complex product needs and challenges. With lives on the line, innovations that support healthcare demand the highest levels of scientific rigor. Whether you’re developing a novel drug, a sturdier stent, or a faster flu test, you need clear answers to complex questions, quickly. Exponent supports our life sciences clients across the total product lifecycle by solving critical design, regulatory, safety, and market access challenges. We can collaborate with you throughout your journey, helping you navigate risks and opportunities — and optimize outcomes — with science-based strategies and specialized expertise.

Stream Biomedical is a clinical-stage biotechnology company developing first-in-class biologic therapies to restore neurological function by activating the brain’s natural repair mechanisms. Founded in 2016, the company is advancing a protein therapeutic focusing on treating brain injuries and neurodegenerative diseases—including stroke, traumatic brain injury, and Alzheimer’s disease—by supporting neurovascular repair and modulating inflammation. Stream Biomedical’s approach is underpinned by rigorous preclinical and translational research, with the goal of changing outcomes for patients affected by severe neurological conditions.

Base Pair Biotechnologies specializes in custom aptamer discovery and development for research, diagnostics, therapeutics, and industrial applications. The company leverages proprietary multiplex selection, advanced bioinformatics, and chemical modification techniques to develop high-affinity and selective nucleic acid aptamers. Base Pair enables affinity reagent development, biosensor design, and molecular detection for a broad range of targets and partners across academia and industry.

Thornhill Medical specializes in advanced medical technologies for critical care, anesthesia, respiratory therapy, and vascular diagnostics. Their core offerings address clinical needs in austere, emergency, battlefield, and transport environments, enabling mobile and integrated life support, portable anesthesia, and precise non-invasive control and measurement of blood gases. With significant expertise in both product engineering and translational clinical research, the company supports deployments worldwide, collaborates with military and civilian partners, and contributes to innovation in healthcare delivery and device interoperability.

Simbex is a leading partner in medical device and consumer health product design and development, recognized for transforming complex ideas into commercially successful solutions. With a multidisciplinary team, Simbex excels in engineering, product design, software, data analytics, and commercialization strategy, supporting innovators from concept to market. Their mission is to deliver impactful medical devices and consumer health products that improve health outcomes and quality of life. Simbex is known for its holistic approach, deep regulatory expertise, and commitment to innovation and excellence in the health technology sector. The company is also active in thought leadership, regularly publishing regulatory and reimbursement updates, and hosting educational webinars for the MedTech community. Simbex maintains a robust Quality Management System compliant with ISO 13485 and FDA 21 CFR 820, ensuring high standards in product development. The company is also committed to supporting diversity in MedTech, including initiatives for women in the sector. Simbex's leadership and advisory team bring decades of experience in biomedical engineering, commercialization, regulatory affairs, and technology innovation, further strengthening its position as a trusted partner in the MedTech ecosystem.

Trimaran Medical Technology Systems Inc. is developing an edge-native, high-acuity medical software and devices engineered for continuous physiological telemetry in remote, austere, and prehospital operational environments.

Aptima, Inc. is a leader in optimizing and improving human performance in mission-critical, technology-intensive environments. Since 1995, Aptima has combined social science principles with advanced computational methods to deliver innovative, human-centered engineering solutions for defense, intelligence, aviation, law enforcement, and healthcare sectors. The company is recognized for its multidisciplinary approach, integrating expertise from engineering, data science, psychology, and cognitive science to address complex challenges. Aptima is committed to advancing research and development in artificial intelligence, machine learning, data analytics, and simulation, with a strong focus on enhancing human-machine teaming, learning, and readiness. Their mission is to ensure synergy between humans, technology, and organizations, accelerating learning and productivity in the age of AI. Aptima's culture is rooted in innovation, impact, and empathy, fostering an inclusive and supportive environment for its diverse team of experts.

Prolucid Technologies Inc. specializes in custom software development for highly regulated industries, including medical and nuclear sectors. With over 17 years of experience and more than 1200 projects completed, Prolucid delivers robust, secure, and compliant software solutions. The company is ISO 13485 certified for medical software and adheres to CSA N299.1 and ISO 9001 standards for nuclear applications. Prolucid offers end-to-end services from project definition and planning to design, development, verification, and ongoing support, leveraging advanced technologies such as AI, ML, computer vision, and cloud infrastructure.

The UVM An-Cockrell Lab Center for Biomedical Digital Twins is a multidisciplinary research group leveraging advanced computational methods, including machine learning, agent-based modeling, and high-performance computing, to study complex biomedical and physiological phenomena. Their mission is to bridge the gap between basic science and clinical interventions by developing digital twins and computational models that inform precision medicine, therapeutic discovery, and translational research. The lab's work spans detailed organ and disease modeling, AI-driven clinical applications, and collaborative projects such as DARPA-funded initiatives, aiming to revolutionize healthcare through technology and simulation.

Martin, Blanck & Associates, LLC (MBA) is a healthcare consulting firm based in Alexandria, Virginia, founded in 1998 by Dr. Edward Martin and Mr. Alfred Giambone. The firm specializes in providing critical assistance to private sector clients, nonprofits, associations, and universities focused on federal healthcare delivery systems, public health programs, and government contracting. With over two dozen senior executive partners and more than 500 years of combined healthcare experience, MBA offers expertise in healthcare policy, program development, executive management, strategic planning, informatics, medical countermeasures, public health strategies, and emerging infectious diseases. The firm is committed to professionalism, ethical service, and delivering results for clients in both the public and private sectors.

Profusa, Inc. is a pioneering digital health company based in the San Francisco Bay Area, dedicated to making the body’s chemistry easily accessible to improve health and wellness. Profusa develops tissue-integrating biosensors for continuous, real-time monitoring of body chemistries, empowering individuals and clinicians with actionable, medical-grade data to transform personal health management and disease prevention. Their unique bioengineering approach overcomes the foreign body response, enabling long-term, in-body monitoring through tiny, flexible biosensors that become one with the body. Profusa’s technology platform supports both consumer and medical applications, with a vision to revolutionize personalized medicine and digital health. The company is supported by significant grant funding from agencies such as DARPA and NIH, and collaborates with leading academic, hospital, and industry partners worldwide.

Policy Wisdom, LLC is a global public health policy consulting firm founded in 2010, dedicated to delivering evidence-based solutions that positively impact public health worldwide. With a mission to be a benchmark of excellence in health policy, Policy Wisdom partners with governments, NGOs, pharmaceutical companies, and advocacy groups in over 150 countries. The company leverages a 100% virtual business model and a diverse, expert team to provide innovative methodologies and client-centered strategies. Their work spans policy strategy development, capacity building, evidence generation, and the creation of educational resources, all aimed at measurable improvements in health systems and equitable health outcomes. Policy Wisdom is recognized for its leadership in decolonizing global health, advancing precision medicine, and shaping policies that address both emerging and persistent public health challenges across the globe.

Cogwear is a US-based neurotechnology company specializing in wearable EEG devices that deliver clinical-grade brain monitoring and analytics outside traditional laboratory or clinical environments. Founded in collaboration with academic neuroscience experts and supported by organizations such as the National Science Foundation, Cogwear's mission is to provide scalable, real-time cognitive and mental health insights for medical, athletic, research, and commercial settings. Their technology platform employs advanced dry EEG sensors and machine learning algorithms for applications including early detection of Alzheimer's disease, behavioral health assessment, concussion monitoring, and neuromarketing analytics. The company is committed to meeting FDA requirements for medical-grade devices while expanding its impact through industry partnerships and scalable manufacturing.

Bethel Biotech specializes in providing advanced genetic sequencing services and expert consultation to empower individuals and researchers with actionable genetic insights. Their mission is to make genetic information accessible and useful for personal health, wellness, and scientific advancement. By offering tailored solutions and ongoing innovation in automation, Bethel Biotech aims to drive forward the frontiers of genetic science and personalized medicine.

Kromek Group plc develops advanced detection technologies for radiological, nuclear, and biological threats using Cadmium Zinc Telluride (CZT) solid-state detectors. The company offers manufacturing and R&D for high-resolution gamma and neutron detectors, networked and wearable monitoring devices, and automated pathogen detection platforms. Its solutions serve the civil nuclear, medical, environmental, defense, and public health sectors worldwide, enhancing safety, operational efficiency, and health security.

MediView XR, Inc. is a Cleveland, Ohio-based med-tech company pioneering the use of augmented reality (AR) and mixed reality to transform medical imaging, surgical navigation, and patient care. Their mission is to advance healthcare delivery with intuitive visualization, seamless collaboration, and evidence-based insights. MediView’s vision is to simplify, democratize, and inform healthcare delivery by unlocking the full potential of 3D data for image-guided procedures. Through partnerships with leading organizations such as GE HealthCare, Mayo Clinic, and Microsoft, MediView delivers AR-powered visualization and navigation solutions that provide clinicians with unprecedented 3D "X-ray vision," real-time collaboration, and improved procedural accuracy. The company is recognized for its innovative approach to addressing health equity by expanding access to advanced care, especially in rural and underserved communities. MediView’s technology is also making significant strides in medical education, enabling immersive, hands-on learning and remote collaboration for students and clinicians.

Flen Health develops, manufactures, and distributes advanced biotechnological solutions for wound and skin healing. Its offerings include topical dressings, gels, cleansers, and educational resources for both clinical professionals and patients. Operating globally in over 40 countries, Flen Health emphasizes research-driven product development, clinical education, and international collaboration to promote inclusive and effective wound care.

The University of Maryland, Baltimore (UMB) is Maryland’s public health, law, and human services university. It is dedicated to improving the human condition and serving the public good through education, research, clinical care, and service. UMB is the founding campus of the University System of Maryland and offers a wide range of professional degrees in health care, human services, and law.

Hyperion Biosystems, an MIT spin-out tough tech company, is developing revolutionary diagnostics at the interface of chemistry, computer vision, and algorithms (both physics-based and AI-enhanced) to address medicine’s most expensive blind spot – sepsis. Our flagship molecular platform (Helios™) is able to simultaneously detect hundreds of target species, direct-from-blood, with excellent sensitivity (single-copy) and specificity (VAFs in excess of 0.0001%). These capabilities are tailer-made for rapid, pre-culture, pathogen ID and AMR marker detection in patients with suspected BSI or sepsis.

4TEEN4 Pharmaceuticals GmbH is a German biotech company pioneering precision medicine in critical care, with a mission to develop causal therapies for acute cardiovascular complications, particularly shock. The company focuses on targeting cDPP3, a key mediator in circulatory failure, and is advancing Procizumab, a first-in-class antibody, through clinical development. With a leadership team boasting over 150 years of pharma experience and a strong network of international researchers, 4TEEN4 aims to address unmet medical needs and improve patient outcomes where current therapies are inadequate.

CellBios is a biotechnology company specializing in the design, development, and manufacturing of single-use bioprocessing and medical device solutions for healthcare, biotechnology, and regenerative medicine sectors. The company operates GMP and ISO-certified cleanroom facilities, offering a comprehensive portfolio of cryopreservation products, bioreactors, fluid management systems, advanced packaging, and specialty devices. By leveraging expertise in extrusion, molding, assembly, sterilization, quality control, and regulatory compliance, CellBios provides customized, scalable solutions to support blood transfusion, cell and gene therapy, biologics manufacturing, and clinical workflows.

Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, dedicated to providing high-quality, patient-centered care. With a history of innovation spanning nearly 150 years, Mayo Clinic is committed to transforming healthcare through research, education, and compassionate care, ensuring that the best possible treatment is available to everyone.

Draper is an independent nonprofit engineering innovation company with a legacy spanning over 90 years, dedicated to delivering transformative solutions for national security, prosperity, and global challenges. Renowned for its pioneering work in guidance, navigation, and control (GN&C) systems, Draper partners with government, industry, and academia to engineer advanced technologies in space, defense, biotechnology, and electronic systems. The company leverages multidisciplinary expertise, digital engineering, and a collaborative approach to provide field-ready prototypes, mission-critical systems, and innovative research. Draper’s mission is to ensure the nation's security and prosperity by delivering sustainable, cutting-edge solutions that address the toughest problems of today and tomorrow, while fostering an inclusive and diverse workforce. Draper also invests in the next generation of innovators through robust educational programs, including internships, co-ops, and the Draper Scholars Program, integrating academic research with real-world problem-solving.

Modus Operandi is a high-tech software and information technology company headquartered in Melbourne, Florida, with over 40 years of experience. The company specializes in developing innovative Living Intelligence solutions that combine human expertise and machine analysis to deliver decision support for complex situations. Their mission is to empower organizations to make smarter, faster decisions by harnessing data and orchestrating advanced analytics. Modus Operandi serves a diverse clientele, including defense, intelligence, and commercial sectors, and is recognized for its commitment to quality, integrity, and customer success.

The University City Science Center (the Science Center) is a 501(c)3 non-profit organization based in Philadelphia, PA. The Science Center catalyzes innovation to maintain the technological superiority of the American military and the strength of the American economy. The Science Center’s core activities include programming to support and train entrepreneurs, commercialize dual use technologies, expand available capital for high growth firms, and cultivate the domestic STEM talent pipeline. We empower early-stage companies to secure and manage federal funding through specialized assistance. By leveraging our government relationships, providing comprehensive proposal development, and deploying sophisticated award management, the Science Center streamlines the process for startups in accessing federal funding. By ensuring that American scientific and technological innovations are rapidly advanced and integrated into defense and dual-use applications, the Science Center strengthens the US industrial base, enhances military readiness, and safeguards national security interests. This lab-to-market pipeline is critical to maintaining technological overmatch, securing supply chain resilience, and reinforcing biosecurity infrastructure. The Science Center’s innovation acceleration initiatives can directly contribute to the Department of Defense’s modernization priorities by reducing reliance on foreign technologies, fostering high-growth industries in critical technology areas, and ensuring that STEM advancements serve as strategic assets to protect and advance US interests. Since its founding, the Science Center’s commercialization and small business programming efforts have supported more than 700 companies, leading to 29,100 jobs with an average salary of $105,000 and $7.6 billion in annual economic impact in Greater Philadelphia. Through its commercialization programs, the Science Center has supported a range of mission-critical innovations that align with DoD priorities, including warfighter readiness, medical technology advancement, and operational resilience.

Benchmark Biotech is a leading contract research organization focused on advancing medical device research and healthcare. Specializing in biotechnology and pharmaceutical development, the company supports the creation of innovative medical devices for trauma and combat casualty care. With a team of experienced scientists, specialists, and physicians, Benchmark Biotech is committed to improving patient outcomes through high-quality research and collaborative partnerships.

Micron Biomedical is a clinical-stage life science company and the leader in dissolvable microarray-based technology for needle-free delivery of vaccines and therapeutics. The company's mission is to radically expand access to treatments and vaccines, improve global health outcomes, and transform how vaccines and drugs are administered. Micron's proprietary technology enables painless, thermostable, and self-administered drug and vaccine delivery, eliminating the need for cold chain logistics and reducing infrastructure barriers. The company is recognized for its innovative approach to overcoming vaccine hesitancy and access challenges, and is rapidly advancing toward commercializing its technology for global impact. Micron partners with leading global health organizations and has secured significant funding to accelerate the development and commercialization of its needle-free solutions.

Aridica Corporation is dedicated to advancing immune system research and clinical applications by providing high-quality, automated immune cell isolation solutions. Their mission is to accelerate the development of diagnostics and next-generation therapeutics by simplifying and standardizing the process of immune cell separation. With a focus on automation, reliability, scalability, and sustainability, Aridica aims to empower researchers and clinicians to unlock the full potential of the immune system for improved health outcomes.

Southwest Research Institute (SwRI) is a nonprofit research and development organization that provides independent, premier services to government and industry clients. Founded in 1947, SwRI is committed to advancing science and technology to benefit humanity, focusing on innovative solutions that improve human health and safety. With a diverse range of technical divisions, SwRI addresses complex challenges in various fields including mechanical engineering, materials, aerospace, automotive, biomedical, and more.

GenVault operates a secure, large-scale biorepository specializing in the storage, management, and logistics of biological and sensitive materials. Serving the life sciences, healthcare, government, and research sectors, GenVault offers robust, regulatory-compliant infrastructure engineered for resilience. The facility supports a comprehensive range of temperature-controlled storage and provides integrated sample management, cold chain logistics, and laboratory relocation services. Quality is maintained through internationally recognized certifications, advanced security systems, and a mature governance structure that emphasizes continuous compliance and operational transparency.

OxiWear is a patient-led medtech company based in Arlington, VA, founded in 2019 by Shavini Fernando. The company is dedicated to reducing patient vulnerability to hypoxic injury through wearable, continuous oxygen monitoring, aiming to increase safety and security for those prone to silent hypoxia, reduce healthcare costs, and save lives. OxiWear's mission is rooted in empowering individuals with chronic conditions to live life to the fullest, leveraging cutting-edge technology to deliver medical-grade, real-time health data. Their FDA-cleared, ear-wearable pulse oximeter is designed for both clinical and at-home use, providing accurate, second-by-second blood oxygen and pulse rate monitoring across all skin tones and during motion. OxiWear is recognized for its innovation, patient-centric approach, and commitment to health equity.

BioFactura, Inc., based in Frederick, Maryland, is a biopharmaceutical company specializing in the development and commercialization of high-value biosimilars, biodefense medical countermeasures, and novel drugs. Leveraging its proprietary StableFast™ Biomanufacturing Platform, BioFactura delivers faster, lower-cost, and superior-quality biologics. With over a decade of experience, the company has advanced life-saving medicines from research to patient care, focusing on unmet global biomedical and national biodefense needs. Its portfolio includes drugs for smallpox, Ebola, cancer, autoimmune, and infectious diseases.

HNu Photonics is a Hawai’i-based science and technology company specializing in the research, design, fabrication, and assembly of advanced photonics, optics, and instrumentation technologies. The company provides integrated solutions across biotech, defense, energy, and advanced manufacturing sectors, offering vertically-integrated services from concept development to finished products. Areas of focus include renewable energy systems, defense photonics, specialized optics, and medical imaging technologies.

Torpedo Therapeutics is dedicated to advancing the field of neurological disorder treatment through high-precision, closed-loop deep brain stimulation (DBS) therapy. Their mission is to enhance the efficacy and safety of DBS by innovating electrode technologies and developing automated data analysis platforms. This approach aims to minimize side effects and improve long-term outcomes for patients with conditions such as Parkinson’s disease, Essential Tremor, Dystonia, and drug-resistant Epilepsy.

Quadridox, Inc. is a pioneering company merging physics with computation to revolutionize X-ray technology for a safer, healthier, and more informed world. Founded in 2018 and headquartered in Hillsborough, North Carolina, Quadridox develops state-of-the-art X-ray tools and technologies, including advanced simulation, synthetic data generation, and X-ray diffraction imaging systems. Their multidisciplinary team of experts delivers innovative software and hardware solutions for security, medical, and industrial applications, serving both government and commercial clients. Quadridox is committed to advancing X-ray system design, analysis, and validation, with a mission to enable rapid, accurate, and cost-effective detection and diagnosis across industries.

JURA Bio is pioneering AI-native drug discovery by bridging the gap between computational design and physical reality in biological AI. Their mission is to revolutionize the discovery and development of safe and effective drugs, making even the hardest therapeutic targets tractable. By leveraging manufacturing-aware generative models, JURA Bio not only designs new therapeutics but also builds, tests, and learns from them at unprecedented scale. Their approach integrates machine learning, synthetic biology, and high-throughput experimentation to create a new paradigm in drug discovery, where AI learns from tens of billions of real protein interactions and every candidate is inherently human-safe.

NTx Bio (Nature’s Toolbox, Inc.) is revolutionizing biomanufacturing by enabling on-demand, decentralized, and scalable production of high-quality RNA and proteins. Our mission is to democratize access to medicines by overcoming the bottlenecks of traditional, centralized manufacturing. Through proprietary, synthetic biology platforms like NTxscribe® (mRNA production) and NTxpress® (cell free protein production), NTx empowers researchers and companies to accelerate the development and delivery of personalized and mass-scale therapeutics, making next-generation medicine more accessible, sustainable, and efficient, while eliminating supply chain concerns by using 100% domestic inputs and production capabilities.

Celestial Therapeutics is a Johnson & Johnson Innovations-JLABS resident California-based biotechnology company focused on developing innovative therapies to treat, prevent, and cure infectious diseases, rare diseases, and cancers. The company leverages groundbreaking science to create dual-modal antivirals/anti-inflammatories, mRNA vaccines, and therapeutics. Founded in 2019, Celestial has rapidly built a diverse portfolio based on its innovative innate immunity platform technologies, aiming to address significant unmet medical needs worldwide.

The University of Louisville Office of Research and Innovation is a premier metropolitan research institution dedicated to advancing knowledge, fostering creativity, and driving innovation across diverse disciplines. Its mission is to support research, scholarship, and creative activity, translating UofL discoveries to benefit Louisville, Kentucky, the nation, and the world. Recognized as a top-tier 'Research 1' university, UofL supports a vibrant ecosystem of research centers, institutes, and collaborative initiatives spanning medicine, engineering, business, and the arts. The office provides robust support for postdoctoral fellows, industry partnerships, entrepreneurship, and access to state-of-the-art core facilities and research tools, making it a hub for innovation, technology transfer, and startup development. UofL is committed to the highest standards of research integrity, compliance, and ethical conduct, ensuring responsible and impactful research outcomes. The office offers comprehensive resources for research participants, including specialized support for children in research, and maintains a strong focus on research policies, technology licensing, industry collaboration, and researcher development through training and funding opportunities. UofL's vision is to support ideas that change, improve, and even save lives, continuously raising the bar for research excellence and societal impact. The office is structured to provide specialized support through dedicated units, research deans, and operational teams, ensuring efficient management and advancement of the university's research enterprise. UofL also maintains transparent and federally compliant practices for indirect cost recovery, ensuring full cost recovery for sponsored projects and providing clear guidance on budget and financials for researchers and partners.

Persist AI is a biotechnology company pioneering the use of AI-driven robotics to accelerate and transform pharmaceutical formulation development. Their mission is to deliver life-saving drugs faster, with fewer side effects, and improved patient outcomes by leveraging advanced automation, machine learning, and high-throughput experimentation. Persist AI's integrated platform addresses the bottlenecks of traditional drug formulation by combining custom robotics, computational chemistry, and proprietary AI models, enabling rapid, scalable, and cost-effective development of complex drug delivery systems such as long-acting injectables. With a global presence and a team of experts in drug delivery, automation, and machine learning, Persist AI is committed to making advanced drug delivery systems more accessible and efficient for the pharmaceutical industry worldwide. The company also demonstrates a strong commitment to data protection, privacy, and security, implementing robust technical and organizational measures in compliance with international standards.

Paragraf specializes in the development and manufacture of wafer-scale, silicon-compatible graphene electronic devices and sensors. Utilizing a proprietary process for direct, contamination-free graphene synthesis, the company delivers scalable solutions for magnetic field sensing, molecular and biosensing, and advanced electronics integration. These technologies address challenges in cryogenics, quantum computing, automotive, aerospace, environmental monitoring, and healthcare. With a focus on large-scale integration of 2D materials, Paragraf advances next-generation sensors and components for demanding and extreme environments.

PulpDigital.ai, founded in 2024, is a healthcare technology innovator dedicated to transforming patient care through advanced artificial intelligence solutions. Their mission is to harness AI to solve healthcare's most complex challenges, empowering providers and improving patient outcomes with innovative, accessible, and ethical technology. The company envisions a world where AI-powered healthcare is seamlessly integrated into clinical workflows, extending provider reach, enhancing patient engagement, and making quality care accessible to all. PulpDigital.ai is guided by values such as patient-first innovation, ethical AI development, collaborative excellence, data privacy, continuous improvement, and global impact. Their approach combines deep healthcare expertise with cutting-edge AI, focusing on real-world challenges and rigorous solution development.

Pennington Biomedical Research Center, a campus of the LSU System, is a global leader in medical discovery and translational science. Pennington Biomedical is dedicated to understanding the biological triggers of disease and nutrition-related conditions. Through basic, clinical, and population research, Pennington Biomedical pursues a bold vision: to lead the world in promoting nutrition and metabolic health and eliminating metabolic disease through scientific discoveries that deliver solutions from cells to society. Building on this foundation, Pennington Biomedical has become a trusted partner in human performance science, with over 30 years of collaboration with the Department of War and a legacy of more than 170 military-focused research projects. This expertise now extends to spaceflight, where Pennington Biomedical seeks to address the physiological demands of long-duration missions. At the forefront of these efforts is the Center for Human Performance Optimization, which unifies military and spaceflight performance science to drive cross-domain innovation. The Center conducts multidisciplinary research to understand and enhance human capabilities under extreme stress. Research spans clinical trials, operational studies, and advanced analytics, with integrated approaches across nutrition, exercise, sleep, pharmaceuticals, cognitive health, and emerging technologies. Studies focus on preventing performance decline and pushing the boundaries of human potential in the harshest environments. Pennington Biomedical’s world-class infrastructure supports this mission. The Clinical Trials Unit includes a 90,000-square-foot outpatient clinic, a 20-bed inpatient unit with metabolic chambers and sleep labs, a metabolic kitchen, dedicated exercise facilities, and flexible-use research space. These resources enable rigorous, multidisciplinary trials. The CTU is further supported by advanced imaging, biochemistry, and data management cores, as well as animal research platforms focused on metabolism, behavior, and comparative biology. Through its integrated platforms and mission-driven focus, Pennington Biomedical is shaping the future of human performance science. The Center for Human Performance Optimization delivers real-world impact for national defense, space exploration, and elite human capability—ensuring warfighter readiness, astronaut resilience, and human excellence across the most challenging environments.

Cepheid is a global leader in molecular diagnostics, dedicated to improving healthcare by developing, manufacturing, and marketing automated, easy-to-use molecular systems and tests. Their mission is to provide rapid, accurate, and actionable genetic testing for a wide range of infectious diseases, oncology, and human genetics. Cepheid's flagship GeneXpert System delivers scalable, sample-to-answer PCR testing for institutions of any size, supporting both centralized and decentralized care. The company is committed to expanding access to high-quality diagnostics worldwide, supporting public health initiatives, driving innovation in molecular testing, and advancing sustainability and responsible business practices.

The Israel Innovation Authority is the central governmental body responsible for fostering and advancing Israel's innovation ecosystem. Its mission is to power innovation through investment, insight, and impactful programs, supporting high-tech entrepreneurship, deep-tech ventures, and global collaborations. The Authority provides non-dilutive funding, strategic support, and regulatory guidance to startups and established companies, ensuring Israel remains a global leader in technology and innovation. With a focus on sectors such as AI, bioconvergence, foodtech, climate tech, and more, the Authority bridges academia, industry, and international partners to address humanity's pressing challenges and drive economic growth. Israel's tech ecosystem, often called the "Startup Nation," is characterized by a culture of bold experimentation, interdisciplinary collaboration, and resilience, making it a global powerhouse for innovation. The Authority also plays a pivotal role in shaping national innovation policy, supporting R&D, and facilitating co-investment opportunities for international investors. The Authority's unique features include proactive future-readiness, risk-absorbing investment models, global market integration, and resilience in times of crisis, such as the deployment of Fast-Track bridging funds to protect startups. The Authority also operates innovation centers and manufacturing accelerators to expand high-tech opportunities geographically and demographically, and regularly identifies and supports emerging technologies with high potential impact. The Authority supports a vast portfolio of startups and scale-ups across diverse sectors, including medical engineering, software, electronics, foodtech, biotech, and more, through programs such as Tnufa, Technological Incubators, R&D grants, and international collaborations.

Prescient Healthcare AI is revolutionizing healthcare delivery through its innovative AI Care Platform, designed to alleviate the economic burden of poor health on US employers and improve patient outcomes. By leveraging advanced artificial intelligence, the platform delivers timely, personalized health insights and interventions, proactively managing chronic diseases and reducing emergency room visits. Prescient Healthcare AI integrates real-time data, such as air quality and environmental factors, to empower individuals and organizations to make informed health decisions, resulting in significant cost savings and improved wellness. The company is committed to seamless integration, user engagement, and a proactive approach to healthcare, making it an ideal partner for sustainable, efficient, and patient-centered care.

Molecular You is a pioneer in predictive, preventative, and precision health, providing advanced molecular analysis to empower individuals and healthcare providers with actionable health insights. Founded in 2014 as a spin-off from the Personalized Medicine Initiative in Vancouver, BC, the company leverages cutting-edge proteomics, metabolomics, and AI to analyze over 250 blood-based biomarkers. Their mission is to make molecular medicine simple, accessible, and impactful, enabling early detection of disease risks and supporting personalized, data-driven health decisions. Molecular You serves both clinics and individuals, offering comprehensive health assessments, personalized action plans, and ongoing progress tracking to foster proactive, transparent, and preventative care. The company’s platform is rooted in rigorous scientific validation, peer-reviewed research, and advanced multi-omic analysis, setting a new standard for precision health and population health management. Molecular You’s unique systems biology approach analyzes interconnected pathways—such as metabolic, cardiovascular, immune, neurological, and hormonal health—providing a holistic view of health that goes far beyond traditional lab tests. Their direct-to-consumer platform enables at-home blood draws and digital health dashboards, and their Action Plan translates biomarker data into tailored, science-backed recommendations for diet, supplements, and lifestyle. The platform’s comprehensive biomarker coverage and AI-driven insights empower both patients and providers to detect and address health concerns long before symptoms arise.

NakedHealth.ai is dedicated to empowering individuals to take control of their health through transparent, AI-driven insights tailored to personalized decisions. The company is committed to equity in healthcare, providing free Electronic Health Records (EHR) services to hospitals in developing regions, and fostering an informed community with open access to healthcare. Their mission is to demystify health complexities, promote transparency, and ensure everyone has access to quality, personalized healthcare. NakedHealth.ai is also focused on innovation, compliance with international standards, and robust security for health data.

Paracrine develops regenerative therapies for chronic wound care, leveraging autologous cell-based treatments and real-time AI platforms to enhance healing precision, predictability, and efficiency. The company operates globally, focusing on scalable and cost-effective biological solutions that integrate advanced machine learning for improved patient outcomes.

The University of Arizona Applied Research Corporation (UA-ARC) is a non-profit organization affiliated with the University of Arizona, dedicated to leveraging the university's strengths in research and education to address national security challenges. UA-ARC aims to deliver innovative solutions and foster collaborations between academia, industry, and government.

BIAGNOSIS specializes in developing advanced psychological diagnostic tools that leverage machine learning and business intelligence. With a foundation in extensive clinical and research experience, the company aims to help organizations optimize business performance by reducing pressures and barriers, enhancing resources, and improving the wellbeing of both employees and customers. Their vision is to bridge human complexity and technology to create flexible, research-based solutions for the modern workplace.

Johnson & Johnson Innovation is dedicated to advancing healthcare innovation through partnerships, venture investing, and incubation. They focus on MedTech and innovative medicine, aiming to foster early-stage innovation and support entrepreneurs in the healthcare sector.

The Institute for Biohealth Innovation (IBI) at George Mason University unites over 300 faculty and thousands of students across 34 departments to advance human health and well-being through innovative research. The IBI focuses on major health challenges, including infectious diseases, cancer, brain and behavior, and cardiovascular health, collaborating with national and international partners to implement solutions that enhance health outcomes.

StethX is a Georgia Tech spin-off developing Dual-Use technologies, Alt-PNT and AI powered wearables. The company is dedicated to advancing cardiovascular and pulmonary healthcare through innovative, wearable medical devices that capture the acoustic fingerprints of the heart and lungs. By leveraging precision wearable technology, machine learning, and artificial intelligence, StethX aims to provide real-time, customized data for patients and clinicians, enabling informed treatments and improved outcomes. Their mission is to make healthcare more accessible, efficient, and personalized, ensuring everyone has access to high-quality, patient-centered care.

Charles River Analytics is dedicated to developing human-centered intelligent systems that enhance military performance, ensure homeland security, and transform healthcare through advanced technology. With a strong focus on AI, robotics, and human-centered computing, the company aims to solve complex challenges faced by government and commercial sectors. The company also emphasizes its commitment to corporate social responsibility, employee ownership, and innovative training solutions.

Inflammasense specializes in advancing healthcare and clinical research through the integration of neural and molecular biomarkers. By leveraging continuous, real-time physiological and molecular data, the company aims to facilitate precision treatments, accelerate clinical trials, and enhance early detection and prevention of critical illnesses such as sepsis and hemodynamic compromise. Their technology platforms including the wearable VITALX-PATCH system that supports clinical trials, defense, and corporate wellness sectors, with a focus on expedited objective decision-making and scalability. The company has secured $4.05 Mil in non-dilutive funding from DARPA, BARDA and the NIH, while it has now closed a total of 1.65 Mil in dilutive funding from KittyHawk Ventures (Pre-seed of $250K) and private investment of (Seed $1.5 Mil). The 2 years long Pre-Seed funding is scoped to obtain FDA 501 (k) clearance of the VITALX-PATCH and complete the in process FDA submission. InflammaSense is seeking $7.5 Mil investment for the clinical trials and product manufacturing to scale for DeNovo approved devices. The approved device is indicated for the first beach head use case as a companion diagnostic for individualized Sepsis therapy.

Senphonix is a MedTech startup dedicated to transforming patient monitoring through intelligent, automated, and continuous vital signs tracking. Their mission is to close the gap between data and action in healthcare, enabling precision, clarity, and compassion for patients, clinicians, and healthcare systems. By leveraging breakthrough wearable technology and secure, cloud-based software, Senphonix aims to reduce clinician burden, improve patient outcomes, and drive efficiency across the continuum of care. The company is headquartered in Minnesota and Arizona, and collaborates with leading academic and healthcare partners to bring next-generation solutions to market.

The Wyss Institute for Biologically Inspired Engineering uses biological design principles to develop new engineering innovations that will transform medicine and create a more sustainable world. At the Wyss Institute, we leverage recent insights into how Nature builds, controls and manufactures to develop new engineering innovations - a new field of research we call Biologically Inspired Engineering. By emulating biological principles of self assembly, organization and regulation, we are developing disruptive technology solutions for healthcare, energy, architecture, robotics, and manufacturing, which are translated into commercial products and therapies through formation of new startups and corporate alliances.

Rattler Medical Solutions focuses on advancing healthcare technology for environments with limited resources. The company provides lightweight, low-power devices that extend the shelf life of biologic products, supporting prolonged field care and resupply in far-forward operations. The mission centers around creating biologic solutions that enhance medical personnel's capabilities in both civilian and operational settings.

Proove Genomics is a leader in predictive health, utilizing advanced genetics and information technology to revolutionize medical decision-making. Their approach focuses on predicting and preventing health issues, thereby enhancing treatment outcomes and reducing healthcare costs. Proove's predictive healthcare model is supported by a vast clinical data bank, aiming to address major health challenges and reduce the leading causes of death.

Versiti is a nonprofit, 501(c)(3) blood health organization dedicated to improving patient lives and supporting healthcare partners through blood donation, innovative research, and advanced diagnostic testing. With locations across the Midwest, Versiti is a leader in blood health innovation, organ and tissue donation, and precision medicine. The organization is committed to enhancing patient care, advancing healthcare standards, and fostering a vibrant donor community. Versiti also supports education through scholarships and is recognized for its compliance and accreditations.

Cloudera, Inc. is a global leader in enterprise data cloud solutions, empowering organizations to transform complex data into actionable insights. With a mission to make what is impossible today possible tomorrow, Cloudera delivers a true hybrid data, analytics, and AI platform for any data, anywhere—from the Edge to AI. The company is driven by open-source innovation and is dedicated to advancing digital transformation for the world’s largest enterprises, providing secure, governed, and scalable solutions across hybrid and multi-cloud environments. Cloudera serves a diverse range of industries, including healthcare, financial services, manufacturing, telecommunications, public sector, and more, enabling customers to tackle transformational use cases and drive value through real-time insights. Cloudera is also a vocal advocate for open standards in machine learning operations and governance, and partners with leading organizations to deliver secure, data-driven innovation worldwide.

Polaroid Therapeutics is a Swiss-based biotech start-up, established in 2022 and incubated by the iconic Polaroid brand. The company is dedicated to addressing major challenges in antimicrobial therapies through cutting-edge technology and research. Its mission is to create a more human, meaningful, and healthier world by developing proprietary antimicrobial polymer technologies that reduce bioburden, improve patient outcomes, and do not trigger antimicrobial resistance (AMR). Polaroid Therapeutics focuses on advanced wound care, medical device coatings, and holistic therapeutic applications, aiming to set new standards in patient-centric care and global health.

Spectral Platforms is pioneering rapid diagnostic solutions in clinical microbiology, focusing on eliminating time-consuming steps in traditional microbiology to enable faster, more accurate detection and characterization of pathogens. Their proprietary technology leverages sensitive detection of bacterial metabolites and redox state changes, providing results in minutes rather than days. The company aims to improve patient outcomes, particularly in sepsis and infectious disease management, by delivering rapid, reliable, and actionable diagnostic information. Spectral Platforms also offers advanced microbiology services and collaborates with leading institutions and regulatory bodies to validate and deploy their innovations.

Triton Genomics develops portable, field-deployable systems for automated preparation of DNA and RNA libraries used in next-generation sequencing (NGS). The company's technology is designed to function reliably in challenging field conditions and to enable rapid, user-friendly, and safe sample processing at the point of collection. Triton Genomics aims to democratize access to advanced genomic analysis for both scientists and non-scientists across diverse application areas such as public health, environmental monitoring, and forensic science.

ClearCure Biosciences is a clinical-stage biopharmaceutical company focused on developing non-toxic, first-in-class and best-in-class therapies for cancer, infectious diseases, sepsis, neurological diseases, and cardiovascular conditions. The company emphasizes drugging challenging targets, leveraging proprietary small molecules, nanotechnology, new oncology cell therapies, new transdermal drug delivery technology, AI and omics-driven approaches, and digital health solutions to address serious unmet medical needs. The company is currently seeking collaborators and partnerships.

Modulim is dedicated to preventing the complications of chronic wounds due to diabetes, peripheral arterial disease, and burns. Mapping tissue health at the point-of-care is key to preventing non-healing chronic wounds. This is made possible only by Modulim's handheld microvascular imaging solution, powered by Spatial Frequency Domain Imaging (SFDI), that empowers healthcare teams with proprietary data and proactive, personalized AI insights.

Hylid Diagnostics develops home-based chronic disease monitoring solutions, focusing on simplified, rapid blood testing, digital data integration, and remote care for conditions such as chronic kidney disease and heart failure. Its technology delivers lab-accurate results from finger-prick samples within minutes and integrates these results into cloud-connected platforms for patient and caregiver engagement. The company aims to reduce the costs and poor outcomes associated with chronic kidney and heart failure by enabling at-home testing and AI-guided remote intervention.

Prolific Machines is pioneering the use of optogenetics and AI-driven bioprocess optimization to revolutionize biomanufacturing. Their mission is to illuminate biology’s limitless potential for a healthier tomorrow by enabling the production of next-generation therapeutics and broadening patient access to life-altering medicines. Founded in 2020, the company has developed a unique Photomolecular™ platform that uses light to precisely control cellular functions, boosting yields, improving quality, and enabling the manufacture of complex biotherapeutics. With a focus on strategic partnerships, Prolific Machines collaborates with innovators in biopharma and advanced nutrition, offering flexible, scalable solutions and in-house cell line development up to 200-liter pilot scale. The company is recognized for its commitment to safety, innovation, and a collaborative, diverse team culture.

NeuroIntact is a medical device company based in Baltimore, Maryland, focused on developing targeted temperature management (TTM) therapies to preserve neurological function in critical care settings, including stroke, traumatic brain injury, and cardiac arrest. The company specializes in intranasal delivery of TTM, aiming to optimize brain temperature while minimizing systemic effects and side effects seen with whole-body cooling. Backed by recent funding and industry partnerships, NeuroIntact is advancing its devices through clinical evaluation and commercialization, with a focus on improving patient outcomes and care for both military and civilian populations.

The University of Massachusetts Lowell (UML) is dedicated to providing a comprehensive educational experience that prepares students for success in their careers and lives. With over 200 degree programs and a commitment to research and community engagement, UML fosters a vibrant learning environment for its diverse student body.

Dandelion Medical Devices (DMD) is dedicated to revolutionizing pulse detection by delivering rapid, objective, and accurate weak pulse detection. Their mission is to eliminate guesswork in critical care by replacing the standard of care, manual palpation—which is only 54% accurate—by providing innovative, patent-protected devices that empower clinicians with real-time, actionable data. DMD's vision is to set a new standard in weak pulse detection, ensuring that every patient receives the highest level of care when it matters most. The company brings together a multidisciplinary team with deep expertise in medicine, engineering, law, and manufacturing, and is committed to advancing healthcare through technology and clinical precision.

RTI International is an independent nonprofit research institute dedicated to improving the human condition. With a vision to address the world's most critical problems through science-based solutions, RTI integrates expertise across social and laboratory sciences, engineering, and international development to deliver reliable data, thorough analysis, and innovative methods that inform public policy and practice.

Kendall Square Sciences is dedicated to designing, developing, and commercializing personal metabolic sensors. Their technology is based on a novel metabolic fuel model and low-cost breath sensor, which measures, tracks, and enhances metabolism. The company aims to provide accurate, affordable, and accessible metabolic measurements to optimize metabolic health with real-time personalized insights.

Red Maple LifeSciences develops smart biomaterial solutions designed to improve the detection and treatment of wound infections by integrating bacteria-responsive hydrogels that enable real-time infection monitoring and targeted antimicrobial therapy.

TETmedical, Inc. is a clinical-stage nanomedicine company specializing in advanced in vitro diagnostic platforms for acute and high-consequence diseases. Originating from research at Cornell University, the company leverages tethered enzyme technologies on nanoparticles to create rapid, sensitive, and robust molecular machines for detection of biomarkers. Their lead product is a rapid functional assay for stroke diagnosis, and their pipeline includes technologies for infectious disease detection and at-home liver function testing.

The University of Georgia (UGA) is dedicated to facilitating instruction, scholarly and creative activity, and research collaborations across disciplines. UGA is a leader in research-based products and innovation, significantly impacting the state of Georgia and beyond through its extensive research initiatives and academic programs.

Southern Research (SR) is a nonprofit preclinical contract research institute that has been bridging basic science and commercial solutions for over 80 years. From pioneering chemotherapy research in collaboration with Memorial Sloan Kettering to generating millions of data points in the global fight against COVID-19, SR has consistently been at the forefront of scientific innovation. Our team of experts excels in transforming cutting-edge science into tangible societal benefits, utilizing comprehensive drug discovery and development capabilities to drive innovation and advance life-saving medical breakthroughs. SR collaborates with over 100 industrial partners, the federal government, and numerous academic institutions to advance the development of life-saving medicines.

Lovelace Biomedical is a not-for-profit preclinical contract research organization specializing in advancing new therapies, assessing drug and toxicant risks, and characterizing disease using comprehensive in vivo and in vitro models. Leveraging a GLP-compliant facility and scientific collaborations, the organization provides expertise in toxicology, gene therapy, respiratory, infectious disease, neuroscience, and cell biology, with a commitment to quality, regulatory compliance, and advanced analytical capabilities.

Ceres Nanosciences, Inc. is a privately held company based in Northern Virginia, specializing in the development and commercialization of Nanotrap® hydrogel particle technology. Their mission is to deliver innovative products powered by Nanotrap Technology to address life science needs and provide better patient outcomes. Ceres' products enable the capture, concentration, and preservation of low-abundance analytes from diverse biological and environmental samples, supporting applications in diagnostics, research, and public health surveillance. The company is ISO 9001:2015 certified and collaborates with leading research institutions, public health agencies, and industry partners to advance global health security and biosecurity. Ceres has established a national network of Wastewater-based Epidemiology Centers of Excellence and has received significant funding from the NIH RADx initiative and other organizations to expand its impact in underserved communities. Their technology is widely adopted for wastewater-based epidemiology, proteomics, and nucleic acid analysis, with a strong focus on supporting public health monitoring, early detection of infectious diseases, and environmental bio-surveillance.

BrightFocus Foundation is a leading nonprofit organization dedicated to funding innovative scientific research and providing expert information to defeat Alzheimer’s disease, macular degeneration, and glaucoma. With a mission to envision a world where everyone can age free from diseases of mind and sight, BrightFocus invests in groundbreaking research, supports the next generation of scientists, and empowers individuals and families with trusted resources. Over its 50-year history, the foundation has awarded nearly $300 million in research grants to more than 6,000 scientists worldwide, catalyzing life-changing breakthroughs and advancing public education on brain and vision health. The foundation's impact is evident in major scientific milestones, such as the first successful cell transplantation for glaucoma, FDA "Breakthrough Therapy" designations, and the development of new diagnostic and therapeutic approaches for neurodegenerative and vision diseases.

The Medical University of South Carolina (MUSC) is South Carolina’s premier biomedical research institution, dedicated to advancing health through innovative research, education, and clinical care. With over $300 million in research funding and a commitment to addressing pressing health challenges, MUSC fosters collaboration among faculty, staff, and community partners to translate scientific discoveries into impactful health solutions. The South Carolina Clinical & Translational Research Institute (SCTR) at MUSC supports innovative research across the translational spectrum, from basic science to population health, including patient-centered and community-engaged research.

Reinvent Health LLC is a U.S.-based medtech company focused on early-stage R&D of scalable, clinically impactful solutions that improve patient care, streamline clinician workflows, and enhance long-term outcomes. At the intersection of clinical insight, engineering design, and translational science, Reinvent Health rapidly prototypes and tests novel technologies to address unmet needs. The company specializes in platform-oriented innovation, technology transfer, and commercial translation through licensing, spinouts, and strategic partnerships. As part of the Tettron Holdings portfolio, Reinvent Health emphasizes device-agnostic, software-driven systems with real-world usability across both hospital and field environments.

Simpli-Fi Automation, Inc. is dedicated to advancing healthcare through connected technologies that enhance the availability and effectiveness of quality care. With a team boasting over 290 years of combined expertise in software engineering, remote patient monitoring, device engineering, infectious disease control, and advanced manufacturing, Simpli-Fi delivers innovative SaaS and IoT solutions. The company partners with leading organizations and leverages patented and patent-pending technologies to develop non-invasive diagnostic and monitoring devices, aiming to transform patient care, improve provider efficiency, and enable early disease detection.

Lumeto is a leader in healthcare simulation using AI and immersive technologies. Its simulation platform is used for training, skills assessment and workforce development in the healthcare, safety, and defense sectors. Their flagship platform, InvolveXR, leverages AI to deliver scalable, customizable, and competency-mapped simulations accessible from anywhere. Lumeto's mission is to revolutionize healthcare and workforce preparedness by providing realistic, data-driven, and engaging learning experiences that enhance decision-making, communication, and patient safety. The company partners with leading academic institutions, healthcare organizations, and technology providers globally, and is recognized for its evidence-based, adaptable, and inclusive approach to training the next generation of first responders. Lumeto is at the forefront of innovation with AI-driven virtual patients, customizable learning modules, and partnerships that extend into remote and space healthcare training. Recent advancements include the launch of industry-first customizable AI non-patient characters, a fully customizable AI-driven conversational system for healthcare simulation in VR, and scalable self-directed learning capabilities. Lumeto's InvolveXR platform is recognized for its flexibility, fidelity, and scalability, supporting both asynchronous and synchronous training, and is validated by research demonstrating significant improvements in clinical training outcomes.

Prosperous Robotics develops advanced digital health and robotics solutions aimed at restoring mobility, independence, and emotional well-being for individuals with mobility challenges. Drawing on global expertise in robotics, AI, and healthcare, the company focuses on digital rehabilitation, intelligent assistive devices, and integrated care platforms. With strategic presence in the US, Europe, and India, Prosperous Robotics collaborates with leading academic, government, and industry partners to scale innovative technologies and transform mobility care.

Vitls is dedicated to transforming patient care through continuous, wireless monitoring technology. Their mission is to provide peace of mind to patients, nurses, and physicians by enabling 24/7 monitoring of vital signs with unobtrusive, wearable medical devices. By pairing their devices with cloud-based data analysis, Vitls empowers healthcare professionals to make quick, informed decisions, improving patient outcomes and reducing delays in care.

Cytonus Therapeutics is pioneering the convergence of artificial intelligence and synthetic biology to revolutionize drug development and delivery. The company challenges the high failure rates of traditional and precision medicines by developing next-generation therapeutics that are both highly effective and safe. Their mission is to create pragmatic shifts in how drugs are designed and administered, focusing on precision, safety, and efficacy to improve patient outcomes.

Digital Infuzion is a CMMI level 3-appraised information technology firm that specializes in innovative computer services, informatics, and enterprise solutions. With a strong focus on healthcare, the company aims to help clients manage, mine, and make sense of data, driving digital transformations across various sectors. The company prides itself on creativity, openness, and growth, fostering a culture that encourages innovative problem-solving and collaboration.

Gel4Med is a commercial-stage company pioneering the use of smart, bioinspired materials to address major challenges in medicine. Founded out of Harvard Innovation Labs, Gel4Med leverages its proprietary Smart Materials Platform™ (SMP™) to develop advanced therapeutics and devices, with a mission to enhance health outcomes and access for all patients. The company is committed to creating novel biomaterials that improve regenerative medicine and surgical solutions, and has achieved significant milestones including FDA clearance for its lead wound care product, G4Derm™ Plus.

Visby Medical develops rapid at-home molecular diagnostic tests powered by polymerase chain reaction (PCR) technology, focusing on accessible, private, and accurate screening for sexually transmitted infections (STIs). The company offers the first FDA-authorized over-the-counter at-home PCR test for women’s sexual health and is expanding its diagnostics platform to address other infectious diseases for point-of-care and home use. Its technology enables results in approximately 30 minutes via a secure mobile app, with integrated telehealth services for positive results. Visby Medical emphasizes user privacy, scalable manufacturing, and partnerships to broaden access to high-quality diagnostics.

Precision Antibody is a leading provider of custom antibody development services, with over 24 years of experience and more than 20,000 successful projects delivered to over 500 organizations worldwide. The company specializes in rapid, high-quality, application-specific monoclonal and polyclonal antibody development, production, and characterization, serving pharmaceutical, biotech, academic, and government clients. Precision Antibody is recognized for its proprietary technologies, award-winning services, and a success rate exceeding 95% in delivering antibodies that perform as intended. Accredited by AAALAC and OLAW, the company is committed to strict quality control, confidentiality, and milestone-based, transparent pricing. Their mission is to enable scientific advancement through innovative, reliable, and tailored antibody solutions.

MATTER is a collaborative community of healthcare innovators dedicated to advancing care, accelerating innovation, and improving lives. The organization provides a platform for startups, corporations, and investors to connect and collaborate on healthcare solutions. MATTER supports entrepreneurs with resources, mentorship, and a dynamic community to foster innovation in the healthcare sector. Since its inception in 2015, MATTER has worked with over 1,000 healthcare technology ventures and partners with industry-leading companies, health systems, and universities.

Instant Systems specializes in the design and manufacture of single-use sterile systems for cell and gene therapy, regenerative medicine, tissue banking, and related bioprocessing applications. The company offers a wide range of customizable solutions for cell culturing, fluid management, media and waste containment, magnetic cell separation, and sterile filtration, with a focus on maintaining process integrity from production through delivery. Their products support closed-system workflows, scalability, and integration into existing manufacturing and research environments.

Surgical Magic develops real-time, AI-driven prediction systems for stroke risk. Using advanced algorithms and standard monitoring inputs, the technology predicts stroke events potentially minutes before they occur, enabling physicians to take preventative actions and improve patient outcomes. The company emphasizes validation and regulatory compliance through multi-site clinical trials and aims to advance operating rooms from reactive to predictive care.

iXpressGenes is a biotechnology company dedicated to transforming trauma care through innovative, science-driven solutions. Their mission is to bridge the gap between mental and physical health by detecting and addressing trauma-induced conditions before symptoms emerge. Leveraging advanced RNA biomarker technology, iXpressGenes empowers healthcare providers to deliver proactive, data-driven care that prevents long-term suffering and improves patient outcomes. The company is committed to early detection, prevention, and the development of tools that legitimize the biological realities of trauma, ultimately redefining the future of trauma care.

Reliable Systems Engineering, LLC is a consulting firm specializing in systems engineering for the medical device industry. The company supports clients—particularly startups, contract developers, OEMs, and CMOs—through expertise in system architecture, requirements development, risk management, verification, and cross-functional coordination. Its mission is to bring clarity, structure, and guidance to complex device development, ensuring regulatory compliance and efficient progress through disciplined engineering practices, all rooted in recognized industry standards and decades of experience.

Index HealthTech develops passive, contactless monitoring infrastructure that detects functional decline and physiological drift before adverse health events occur—without wearables, cameras, or subject compliance. The company’s patent-pending Sense™ platform uses mmWave radar and far-field acoustics to continuously measure respiration, mobility, sleep, gait, and behavioral patterns across six domains. These signals are translated into the Healthy Habits Index™ (HHI™), a 0–100 behavioral biomarker that quantifies functional status and change over time. At the system level, Index HealthTech models individual trajectories to identify early-stage decline patterns before they become clinical events or mission-limiting conditions—enabling intervention during the narrow window where outcomes can still be altered. The platform is designed for environments where traditional monitoring fails: uncontrolled living spaces, high-throughput care settings, and operational environments where compliance-dependent tools are impractical. It requires no physical contact, no per-user calibration, and no behavioral change from the monitored individual. Backed by over $5M in NIH and NIA funding, Index HealthTech is advancing a new class of continuous behavioral biomarkers with direct application to warfighter health monitoring, veteran care, traumatic brain injury recovery, PTSD-related behavioral drift, and post-deployment readiness assessment.

Vascular BioSciences is a biopharmaceutical and medical device company focused on developing targeted therapeutics, minimally invasive interventional devices, and advanced molecular diagnostics for cardiovascular, pulmonary, and inflammatory diseases. The company leverages targeted peptide drug delivery, endovascular tissue sampling, molecular profiling, and bioinformatics to advance personalized medicine for difficult-to-treat diseases. Its operations span California and North Carolina with expertise in biologics, device engineering, and translational research.

Adaptyx Biosciences develops a wearable platform that turns laboratory-grade biochemical assays into continuous molecular data streams. The company enables minimally invasive, real-time monitoring of diverse biomarkers through programmable molecular sensors combined with advanced electronics and AI-driven analytics. The goal is to provide actionable, continuous health insights for clinicians, facilitating proactive, personalized, and always-on healthcare. The technology is designed for versatility across high-impact use cases such as heart failure management, chronic kidney disease, hormone dysregulation, hospital care and precision drug monitoring. The platform is based on a decade of academic innovation, integrating high-throughput molecular engineering, data-driven design, and robust clinical-grade performance.

CureLab Veterinary is a biotechnology company focused on the development of gene-based therapies targeting cancer and chronic inflammatory diseases in companion animals, such as dogs, cats, and horses. Utilizing advances in comparative medicine and translational immunology, the company applies a plasmid-based platform to stimulate anti-cancer immune responses, modulate tumor microenvironments, and mitigate chronic inflammation. Clinical research leverages academic partnerships and a robust intellectual property portfolio, pursuing efficient regulatory approval pathways in major markets, including the US and Europe. Recent studies suggest broader applications in pain management and cross-species translational potential.

Tria Federal is a premier provider of digital services and technology solutions for the federal government, with a mission to support the health, safety, and operational excellence of veterans, service members, and civilians. Formed through the integration of several legacy companies and the acquisition of Softrams in 2024, Tria delivers end-to-end solutions that modernize, streamline, and transform government systems. The company is recognized for its values-driven culture, commitment to diversity and inclusion, and impactful community engagement. With nearly 1,000 employees across more than 40 states, Tria leverages deep expertise in IT, advisory services, and digital transformation to power possible for its government partners.

LMI is a premier provider of commercial-grade technology and consulting solutions for government agencies, accelerating mission success through innovation, advanced analytics, and digital transformation. With a focus on AI-enabled delivery, rapid platform engineering, and mission operations, LMI leverages low-code/no-code tools, secure modular platforms, and deep federal expertise to solve complex challenges at commercial speed. The company is recognized for its commitment to research, strategic partnerships, and workforce development, empowering government missions ahead of need and ensuring adaptability, efficiency, and future-proof outcomes. LMI's leadership and experts drive impact across defense, intelligence, health, and civilian markets, supported by a culture of innovation and collaboration. LMI's internal R&D studio, LMI Forge, and its team of subject matter experts, further reinforce its position as a leader in mission-focused technology and agile transformation.

Vira Regen is a regenerative biotech company pioneering a new class of gene-specific bioelectronic medicines designed to accelerate the body’s natural healing processes. By harnessing the body’s bioelectric network and genetic signaling pathways, the company is developing noninvasive electroceutical therapies targeting bone fracture healing, musculoskeletal injuries, osteoarthritis, osteoporosis, and cancer. Focused on addressing the root causes of disease and tissue damage, Vira Regen aims to redefine regenerative medicine through precision bioelectric therapeutics that promote faster, more effective recovery and tissue regeneration.

TISTA Science and Technology Corporation delivers technology, analytics, and digital transformation for federal agencies, with emphasis on healthcare, supply chain optimization, fraud prevention, and IT modernization. The company integrates artificial intelligence, cybersecurity, cloud, and data engineering expertise to modernize mission-critical systems, enhance operational efficiency, and improve public service outcomes. TISTA is recognized for its application of human-centered design, agile methodologies, measurable impact, and commitment to serving veterans and addressing federal challenges.

Imbed Biosciences is a privately held medical device company that specializes in the development of advanced devices for the treatment of burns, ulcers, and soft-tissue repair. The company is committed to providing innovative solutions that improve patient care and outcomes through its patented Microlyte® Matrix technology.

Lunai Bioworks Inc. is an AI-powered company at the intersection of drug discovery, diagnostics, and biodefense. The company integrates generative AI, proprietary neurotoxicity and chemical datasets, multi-omics, and high-throughput in vivo models to identify and validate therapeutic targets, biomarkers, and to safeguard against dual-use biosecurity risks. Lunai Bioworks partners with academia, industry, and government to advance safe and responsible AI-enabled biomedical innovation, spanning oncology, neurology, precision medicine, and countermeasure development for chemical and biological threats.

Battelle is an independent nonprofit organization dedicated to advancing science and technology to address the world's most pressing challenges. With over 90 years of experience, Battelle transforms knowledge into profound innovation, reinvesting its proceeds into scientific advancement and STEM education. The organization operates across various markets, including health, national security, environment, infrastructure, and industry, providing solutions through limitless innovation and expertise in scientific and engineering disciplines.

DANE Health, Inc. created an Agentic Medical AI assistant, initially concentrating on neurology and triage to revolutionize care pathways. The company provides individuals and healthcare professionals with practical insights, tailored support, and professional reports, all while ensuring privacy and security. Our AI agent engages in lifelike conversations to tackle complex management or recovery challenges, while monitoring progress over time. DANE Health aims to supply clinicians with clear data to improve patient care and aid in better recovery.

Zymo Research is a global biotechnology company specializing in innovative products and services for sample collection, nucleic acid purification, microbiomics, epigenetics, and next-generation sequencing (NGS). With over 30 years of experience, Zymo Research is recognized for simplifying complex scientific workflows and providing reliable solutions for life science research, clinical diagnostics, and molecular biology applications. The company offers a comprehensive portfolio of kits, standards, and services designed to ensure accuracy, reproducibility, and efficiency in molecular analyses, supporting researchers worldwide.

Since 2002, Bluehalo Labs has established itself as a key federal contractor capable of delivering sophisticated technological products and engineering services across multiple domains. Based in Albuquerque, New Mexico, the company provides a diverse range of engineering, research and development, and technological services, with a strong focus on areas including space superiority, directed energy, missile defense, C4ISR, cyber/intelligence, and advanced sensor systems. Through its federal contract awards, Bluehalo Labs has provided an extensive array of goods and services to various agencies, including the Department of Defense, Air Force, Navy, Army, and civilian agencies like Customs and Border Protection and the Federal Railroad Administration. The company's contract work spans multiple technological domains, including developing unmanned aerial systems, sensor pod systems, radar equipment, optical communications systems, battle management software, and advanced research initiatives.

Melio is developing a rapid, culture-free bloodborne pathogen testing platform integrating proprietary assays, microfluidics, and machine-learning. The company targets faster and more accurate infectious disease diagnoses, aiming to reduce antimicrobial misuse and address antibiotic resistance. The platform is designed for comprehensive, direct-from-blood detection of a broad spectrum of pathogens, with a focus on real-time adaptability to new and emerging threats. Melio's system is in development and not yet commercialized.

Biophoundry specializes in advancing scalable engineered phage-based solutions for therapeutics, diagnostics, and bio-molecular engineering. It is shifting the paradigm from phage discovery to phage design. Its team leverages expertise in synthetic biology, machine learning, and data science to accelerate the development of precision antibiotics and address critical healthcare challenges such as antimicrobial resistance.

Rajant Corporation is a pioneer in Kinetic Mesh® technology, providing mission-critical wireless networks that ensure continuous connectivity in dynamic environments. Their solutions are designed for various industries, including defense, mining, healthcare, logistics, and public safety, enabling real-time data communication and enhancing operational efficiency. Rajant's commitment to innovation and adaptability positions it as a leader in the wireless communication landscape. Founded in 2001, Rajant has grown to serve over 75 countries, establishing a strong international presence and a reputation for delivering scalable and adaptable wireless solutions.

Texas Biomedical Research Institute is dedicated to pioneering and sharing scientific breakthroughs to protect global communities from infectious diseases. With over 80 years of experience, it combines high-level biocontainment labs, a National Primate Research Center, and a commitment to advancing diagnostics, vaccines, and therapies. The institute also emphasizes education and outreach, providing resources and programs to engage students and teachers in scientific research.

The University at Buffalo is a leading public research university and flagship of the SUNY System, recognized for its innovative research and commitment to societal impact. It aims to transform scientific and technological breakthroughs into global impact, addressing complex challenges through interdisciplinary collaboration.

BDR Solutions, LLC is a Service-Disabled Veteran-Owned Small Business (SDVOSB) founded in 2016 by U.S. Navy Veteran Bob Rowe. The company is dedicated to improving healthcare outcomes for Veterans, service members, and their families by leveraging innovative technology and compassionate care. BDR specializes in modernizing government systems in health, social services, and disaster relief, with a mission to deliver impactful, tech-driven solutions that exceed mission objectives for diverse government clients. Their vision is to anchor the future with tech-driven health for the nation’s heroes, ensuring the highest quality support across all sectors.

Principle Diagnostics is a state-of-the-art clinical and anatomic pathology laboratory founded in 2015, specializing in toxicology, molecular, and genetic testing. Licensed in over 40 states and led by an executive team with over 50 years of cumulative experience, Principle Diagnostics is committed to operational efficiency, adaptive innovation, and personalized service. The company serves a diverse clientele—including individuals, medical facilities, and research organizations—across sectors such as pain management, substance abuse, podiatry, urology, long-term care, memory care, and assisted living. Principle Diagnostics aims to be a leader in diagnostic services by continuously expanding its comprehensive test menu and upholding values of integrity, service, excellence, and innovation. The company is recognized for its strong focus on compliance, financial integrity, and the integration of advanced therapeutic management and antibiotic stewardship programs. Principle Diagnostics is also celebrated for its commitment to ethical principles, teamwork, and inspired people, striving to set an example in the industry for trust, credibility, and patient-focused outcomes. In 2024, Principle Diagnostics celebrated a decade of pioneering advancements in pharmacogenomic (PGx) testing, further cementing its role as an innovation leader in personalized medicine.

ZOLL Medical Corporation, a subsidiary of Asahi Kasei, is a global leader in developing and marketing medical devices and software solutions aimed at advancing emergency care and improving patient outcomes. Founded in 1980 and named after Dr. Paul Zoll, the company is renowned for its innovative technologies in defibrillation, cardiac monitoring, and other critical care solutions. ZOLL is committed to enhancing clinical and operational efficiencies, supporting healthcare professionals and lay rescuers worldwide in addressing serious cardiopulmonary and respiratory conditions.

Vista LifeSciences is dedicated to improving health and innovating solutions across various environments, including urban, rural, and remote areas. The company specializes in cognitive and behavioral health assessments through its Automated Neuropsychological Assessment Metrics (ANAM) and offers mobile software solutions for patient management and population health.

UC San Francisco is a leading university dedicated to advancing health worldwide through preeminent biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. With a commitment to public service, UCSF aims to innovate health care approaches for vulnerable populations and train the next generation of health professionals.

InformedDNA is a leading precision health company dedicated to revolutionizing the application and implementation of genomic insights to enhance patient care and improve outcomes for all. With over 15 years of experience and the largest in-house staff of board-certified genetics specialists in the U.S., InformedDNA combines deep genetics expertise and advanced technology to deliver real-time, evidence-based solutions for optimizing clinical decisions, improving outcomes, and realizing cost savings at scale. The company supports payors, providers, employers, life sciences, and patients with equal access to genomics clinicians, genetic counselors, and tech-driven solutions. InformedDNA is committed to advancing personalized healthcare, health equity, and cost-effective care, shaping the future of precision health through ongoing innovation, education, and a strong focus on integrity and patient privacy.

Brinter is a pioneering US-based MedTech firm focused on revolutionizing tissue engineering through the development of 3D bioprinted biocomposite regenerative implants, known as BioMods™, which aim to restore damaged tissue and replace conventional implants, launching in orthopedics/tendons and ligaments. The company driven by a team of visionary entrepreneurs and leading bioscientists and engineers.

Opticyte is a medical device company dedicated to transforming the standard of care for hemorrhage, sepsis, and other leading causes of organ failure. Their mission is to save lives through early detection and real-time measurement of cellular and blood oxygen levels, providing accurate diagnostics for all skin tones and addressing critical health equity issues. Founded in 2016 as a spinout from the University of Washington, Opticyte is pioneering the first device to measure oxygen inside cells in real time, aiming to reduce organ failure and death associated with hemorrhage, sepsis, and other critical illnesses. The company is recognized for its innovative approach, commitment to health equity, and strong leadership in medical technology.

Calla Lily Clinical Care develops patented medical device technologies engineered to improve intravaginal drug delivery for women's health, focusing on clinical needs such as fertility support, pregnancy management, prevention of recurrent miscarriage, and restoration of the vaginal microbiome. Recognized for innovation, the company maintains collaborative partnerships with clinical and academic institutions and secures funding to advance clinical trials and R&D. Their technology is designed for leak prevention, convenience, and dosing confidence, with a strong commitment to sustainability and social impact as a certified B-Corporation.

MaXentric Technologies is a privately held company that designs and manufactures high-performance electronic solutions for the defense, medical, and commercial industries. Founded in 2003, MaXentric develops compact sensing, monitoring, and communications platforms that support patient assessment, physiological monitoring, and continuous care in austere far-forward environments. This includes advanced medical monitors, contactless vital-sign sensing, ingestible and self-powered biosensor platforms, and automated health data systems. Our company’s long history in RF, embedded, and signal-processing technologies underpin much of our medical technologies. With multidisciplinary teams across three U.S. locations, MaXentric combines hardware, firmware, signal processing, and user-interface development to move innovative medical technologies from concept to deployable systems.

UTHealth Houston is Texas’ resource for health care education, innovation, scientific discovery, and excellence in patient care. Since 1972, UTHealth Houston has been dedicated to educating the next generation of health care professionals, advancing biomedical research and public health, and providing exceptional care to communities. With half a century of experience, it is one of the nation’s most comprehensive academic health centers, committed to advancing the quality of human life through education, research, and clinical practice.

NXTech is a translational science company building signal processing and neuromodulation systems to enhance human performance. Our mission is to commercialize breakthroughs in cognitive science and engineering; addressing unmet medical needs, both in-field and at the homefront.

Cook MyoSite, a subsidiary of Cook Group, has been advancing human muscle cell technology since 2002. Operating under ISO 9001:2015-certified quality standards, we specialize in primary human skeletal muscle-derived cells and fibro-adipogenic progenitors sourced from healthy donors and individuals with neuromuscular, metabolic, and rare disorders. Our offerings include custom cell procurement, specialized media formulations, and contract manufacturing services—supporting both academic research and clinical development in regenerative medicine. Beyond research tools, Cook MyoSite is pioneering autologous muscle-derived cell therapies. Our investigational product, iltamiocel, is currently in a Phase III clinical trial for fecal incontinence, demonstrating our commitment to translating cell-based science into real-world solutions. With expertise in GMP manufacturing, analytical testing, and tailored partnerships, we empower collaborators to accelerate innovation in musculoskeletal and neuromuscular health worldwide.

VitaKey is pioneering a new era in nutrition by applying precision delivery technology to enhance the nutrient density of foods and beverages. Developed at MIT, Langer Lab, and co-founded by Dr. Robert S. Langer, VitaKey's platforms aim to address global health challenges, including diet related diseases such as obesity, heart disease and diabetes. VitaKey technologies ensure the stability and controlled release of nutrients (macronutrients, micronutrients, probiotics, bioactives, etc.) to improve bioavailability and enhance the functionality of foods and beverages. VitaKey creates all natural food and beverage solutions to enhance human performance, boost satiety, and improve the health and wellness of all consumers.

Hemanext is a privately held medical technology company specializing in oxygen-controlled red blood cell processing and storage systems for transfusion medicine. The company develops, manufactures, and commercializes innovative storage solutions that preserve the quality and function of red blood cells by limiting oxygen and carbon dioxide exposure, with the goal of improving transfusion outcomes for patients with chronic and acute conditions. Hemanext's products have received FDA De Novo marketing authorization and CE Mark certification, enabling global distribution. The company is recognized for its focus on scientific evidence, operational compatibility, and strategic partnerships with blood establishments and clinical researchers.

Prepaire Labs develops an open platform for drug discovery and disease modeling, with a focus on personalized medicine through genetic insights. Its offerings include AI-powered analysis, an app store for scientific applications, and bioinformatics developer tools. The company's infrastructure supports advanced lab work, genome sequencing services, and biobanking to accelerate therapeutic innovation.

IonTX Inc is a biotech startup working towards the future of precision medicine for pain conditions and for neurological and psychiatric illnesses. The company is further developing our patented and licensed non-opioid small molecule for acute and chronic pain associated with battlefield trauma. IonTX has developed a next-generation ion channel modulator that harnesses the incredible power of intracellular helper proteins to normalize abnormal cell firing that maintains and progresses pain. The team consists of academic and industry experts specializing in chemical science, neuroscience, pharmacology, and CNS drug discovery.

Aiming to minimize radiology error of 30% in healthcare delivery, XENSE 's Meta CT /AI  technology offers accurate standardized real time 3D imaging & 3D physical model for healthcare delivery of critical illnesses with ultralow x-ray radiation,  replacing  traditional CT , fluoroscope, general x ray, densitometer and other medical x modalities and related AI solutions  used in prediction, diagnosis and intervention guidance with one AI powered compact device with higher performances previously not possible.  With initial fundings from NASA and Department of Transportation, based on 30+ years of R & D and effort of two generations of engineers/physicist/molecular biologist from MIT,  Harvard Medical School, Columbia University and Boston University, the first Meta CT / AI aims to  minimize radiology errors, dramatically reduce radiation exposure, significantly lowering costs for the healthcare delivery and minimizing time to diagnosis, intervention & wellness. XENSE has filed 70+ and been granted multiple patents in imaging hardware, algorithms, AI and supporting technologies, though its primary products are currently in development and not yet FDA approved for commercial use.

VitaCyte specializes in the manufacture and supply of GMP Grade purified-defined collagenase and protease enzymes for cell and tissue dissociation. The company is dedicated to supporting researchers, commercial cell suppliers, and institutions involved in cell therapy and transplantation, providing high-quality products that enhance the efficiency and effectiveness of cell isolation processes. VitaCyte is committed to improving the science of cell recovery and has a history of innovative solutions in the field of cell isolation, contributing to significant advancements such as the Edmonton Protocol for islet transplantation. Their products, particularly the purified-defined collagenase, ensure high lot-to-lot consistency and rigorous enzyme characterization, setting a standard in the industry.

Document Storage Systems, Inc. (DSS, Inc.) is a leading health information technology (HIT) software development and systems integration company with over 30 years of experience. DSS delivers innovative, secure, and efficient healthcare technology solutions and services used daily by thousands of clinicians and administrative staff nationwide, across federal, private, and public healthcare sectors. The company is dedicated to improving productivity and healthcare delivery, with a strong focus on digital transformation, interoperability, regulatory compliance, and above all, patient care. DSS is recognized for its deep expertise in modernizing legacy systems, supporting the Department of Veterans Affairs, and delivering solutions that enhance provider performance and patient outcomes. DSS is a member of the Open Source Electronic Health Record Agent (OSEHRA) and a founder of the VistA Extension Hub, fostering open source collaboration in healthcare IT. The company is also known for its rapid nationwide implementations, strategic partnerships, and a legacy of enabling significant cost savings and operational efficiencies for the VA and other healthcare organizations. DSS has been repeatedly recognized in the Healthcare Informatics Top 100 list of leading healthcare IT vendors, reflecting its industry impact and growth.

Novel Microdevices, Inc. is a woman-owned, woman-led company based in Baltimore, Maryland, specializing in the development of ultra-portable, rapid, point-of-care molecular diagnostic systems. Their mission is to revolutionize infectious disease diagnostics, particularly for women’s health and under-resourced populations, by providing fast, accurate, and affordable testing solutions. Their flagship platform, Novel Dx, is designed to deliver lab-quality results in under 15 minutes, enabling immediate diagnosis and treatment at the point of care. The company is committed to addressing global health challenges, including antibiotic-resistant infections, through innovative technology and strategic partnerships.

RTM Vital Signs LLC is a Philadelphia-based medical device company focused on transforming healthcare from reactive and hospital-centered to preventive, proactive, evidence-based, and person-centered. Specializing in real-time sensing, monitoring, and analysis of critical health information, RTM Vital Signs targets cardiovascular and respiratory health. The company leverages proprietary, cost-effective monitoring technology, advanced sensors, and AI-driven diagnostic algorithms to provide continuous, real-time health status tracking for both hospital and ambulatory patients. Their mission is to enable better health outcomes, lower costs, and improve patient and staff experiences through innovative wearable devices and continuous monitoring solutions. RTM's patented solutions are designed for seamless integration with smart devices and wearables, supporting timely diagnosis, predictive analytics, and improved telemedicine capabilities. Their technology also addresses key public health challenges such as hypertension, respiratory compromise, and opioid-induced respiratory depression, with applications extending to fitness, industrial safety, and veterinary medicine.

Pressure Medical develops advanced medical devices focused on severe hemorrhage control and trauma care, particularly for military and high-risk civilian environments. The company specializes in smart pneumatic and junctional tourniquets designed for rapid and effective bleeding control in emergency situations, emphasizing ease of use, minimal training requirements, and patient limb preservation. With multiple issued patents and collaborations with government and defense agencies, Pressure Medical aims to enhance combat medical care and improve survival outcomes through innovative biomedical engineering.

Corscience is a German-based medical technology development and manufacturing provider specializing in advanced solutions for defibrillation, patient monitoring, and vital sign acquisition. The company supports OEMs and medtech startups internationally with expertise across R&D, regulatory affairs (including MDR and FDA compliance), quality management, lifecycle management, and technical consulting. Their track record includes the delivery of complex, safety-critical systems and robust integration of electronic, software, and mechanical components in medical devices.

QoreHealth is dedicated to transforming healthcare accessibility through AI-powered, portable diagnostic and telemedicine solutions. Our mission is to enable rapid screening, early detection, and specialist-guided interventions in emergency, remote, and underserved environments. By integrating advanced mobile technology, edge computing, and real-time data, QoreHealth aims to deliver scalable health impact and drive global health equity.

Riptide Bioscience develops engineered peptides derived from host defense peptides found widely in nature. Their focus is on creating peptide-based therapeutics for cancer, inflammatory diseases, and microbial infections, especially those resistant to conventional treatments. The company advances both preclinical and early-stage clinical programs, collaborates with academic partners and government agencies, and holds patents for its engineered peptide design technologies.

Genomind is a leader in precision medicine for mental health, dedicated to helping healthcare providers and patients make better prescribing decisions by leveraging genetic, lifestyle, and environmental data. Their mission is to personalize mental health treatment and improve outcomes for individuals, providers, and healthcare systems. Genomind supports a wide range of stakeholders, including individuals, providers, long-term care facilities, ACOs, employers, health plans, and international partners. Through innovative pharmacogenetic testing, precision medicine software, consultative services, and educational resources, Genomind aims to advance mental health care and empower both patients and professionals.

Epicore Biosystems is a digital health company specializing in biowearables for non-invasive monitoring of hydration, metabolic health, and stress through sweat analysis. Their solutions support industrial workers, athletes, and clinical researchers by converting sweat biomarkers and physiological data into actionable insights for real-time health, safety, and performance management. The company combines expertise in data science, material science, and biomedical engineering to create validated, user-centric wearable technologies, and partners with organizations across healthcare, academia, industry, and public health sectors.

Fluxergy Inc. is a company focused on revolutionizing point-of-care testing with its innovative, multimodal platform. The company aims to bring laboratory capabilities directly to patients, offering rapid, accurate, and cost-effective diagnostic solutions. Fluxergy's technology is designed to streamline testing processes, making it accessible and viable for clinical and community-level applications. Their mission is to enhance biosecurity and improve diagnostic efficiency across various sectors, including clinical diagnostics and veterinary medicine.

The Vanderbilt School of Engineering is a globally recognized academic and research institution dedicated to producing leaders and innovators in engineering. With a commitment to solving grand challenges, the school offers a diverse range of undergraduate and graduate programs across multiple engineering disciplines, fostering a culture of collaboration and excellence.

The Medical College of Wisconsin (MCW) is dedicated to transforming healthcare through innovative education, research, and patient care. With a focus on academic medicine, MCW aims to improve the health of communities by fostering a collaborative learning environment that integrates medical education with groundbreaking research and comprehensive patient care.

Headache Sciences Inc. is a clinical artificial intelligence company pioneering the diagnosis and monitoring of headache disorders, with a primary focus on migraine. Leveraging advanced EEG (electroencephalography) technology and machine learning, the company has developed the world's first objective test for migraine, aiming to address the global challenge of underdiagnosis and misdiagnosis. Their mission is to provide practitioners with innovative tools to improve diagnostics, monitoring, and treatment of headache-related neurogenic and neurodegenerative disorders. With a vision of translating brain electrical activity into a comprehensive suite of diagnostic and monitoring services, Headache Sciences Inc. stands at the forefront of Software as a Medical Device (SaMD) innovation, offering hope through discovery.

Partner Therapeutics, Inc. (PTx) is a commercial-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for cancer and other serious diseases. With a strong foundation in oncology, PTx also leads research in infectious diseases, immunology, and urgent clinical needs such as COVID-19 and sepsis. The company integrates research, manufacturing, development, and commercialization to rapidly bring therapies to patients worldwide, emphasizing collaboration with medical and scientific communities to improve patient outcomes and quality of life. PTx's mission-driven approach is supported by a leadership team with deep industry experience and a commitment to advancing late-stage therapeutics that address significant unmet medical needs. The company also maintains a robust compliance program in accordance with state and federal regulations.

Devah Therapeutics specializes in repurposing proven pharmaceutical molecules, applying contemporary scientific approaches to address stress-related, metabolic, and neuropsychiatric conditions that lack effective treatments. By utilizing the FDA 505(b)(2) regulatory pathway, the company accelerates drug development, minimizes clinical risk, and explores new indications for molecules with established safety. Their focus is on restoring resilience and quality of life through therapies underpinned by mechanism-based science. The company's lead program is based on a chemistry estate with decades of safe use, targeting multiple indications through targeted modulation of neurobiological and metabolic pathways.

Exactics specializes in the development of rapid, affordable, and accurate at-home diagnostic tests for infectious diseases. The company employs a consumer-oriented design and scalable technology platforms to provide point-of-need diagnostics that aim to increase early disease detection and convenience, with a focus on lowering costs and minimizing development timelines.

Diadem Biotherapeutics is a biotechnology company focused on developing first- and best-in-class therapeutics by engineering extracellular vesicles to modulate immune responses. Their mission is to innovate beyond existing solutions to address unmet medical needs, leveraging expertise in immunology, bioengineering, and drug development. The company’s proprietary DECOSTAR™ platform enables precise costimulatory activation or repression of immune cells, targeting a range of diseases including cancer and autoimmunity.

Biobeat is a global leader in wearable remote patient monitoring technology, revolutionizing hypertension diagnosis and management through innovative, non-invasive, cuff-less blood pressure monitoring systems. Their mission is to ensure all hypertension patients are monitored and managed effectively, empowering healthcare providers with accurate, real-time data to optimize patient care. Biobeat leverages proprietary patented PPG sensor technology and advanced data analytics to deliver continuous, medical-grade monitoring solutions that enhance clinical decision-making, improve patient compliance, and enable proactive interventions. With FDA-cleared and CE-certified devices, Biobeat is committed to transforming healthcare delivery, supporting both in-hospital and home-based care, and driving better patient outcomes worldwide.

MedTech Innovator is the world's largest accelerator for medical device, digital health, and diagnostic companies. Their mission is to improve patients' lives by accelerating the growth of companies transforming healthcare worldwide. They offer programs and resources to support innovators in the medtech industry, including webinars, fellowships, and strategic partnerships.

MyFitStrip is a precision wellness platform advancing oral and metabolic health by restoring nitric oxide (NO) bioavailability through clinically grounded, microbiome-directed interventions. Built on validated nitrate–nitrite–NO biology, MyFitStrip uses topical oral delivery (chewing gums and lozenges) to enhance nitric oxide production directly within the oral microbiome—supporting beneficial bacteria (e.g., Neisseria, Rothia, Veillonella) while suppressing pathogenic species linked to inflammation, caries, and infection risk. This approach targets a critical physiological pathway, with evidence linking nitric oxide to vascular function, immune defense, and metabolic health, including improvements in endothelial function, blood pressure regulation, antimicrobial activity, and oral pH balance. The platform is complemented by rapid saliva-based test strips that measure nitric oxide status, pH, and uric acid—creating a closed-loop system that drives personalization, compliance, and real-time lifestyle feedback. MyFitStrip’s product suite includes prebiotic chewing gums, slow-release lozenges, and diagnostic strips, all supported by a portfolio of nitric oxide–related patents and a deep body of clinical and scientific research spanning immunology, cardiovascular health, and microbiome science. MyFitStrip is defining a new category at the intersection of oral microbiome modulation and nitric oxide biology, enabling scalable, non-invasive solutions for oral-systemic health optimization.

Houston Methodist Academic Institute integrates advanced clinical research, education, and healthcare innovation with a focus on translating scientific discoveries into improved patient outcomes. The institute offers accredited graduate and postgraduate medical education, supports interdisciplinary research in major areas such as cancer, cardiology, neuroscience, transplant medicine, and regenerative medicine, and provides extensive infrastructure for digital health and medical technology development. Training and fellowship programs span from medical residencies and fellowships to doctoral and research-oriented positions, supported by collaborations with leading academic and industry partners. The institute leverages core technology platforms, simulation centers, and comprehensive educational pathways to foster future leaders in medicine and biomedical research.

ARIScience is at the forefront of drug discovery, leveraging a unique combination of AI, quantum chemistry, computer vision, and biochemistry to develop novel small molecule drugs. Their mission is to reduce the burden of human disease by discovering therapeutics that interrupt disease pathways. With a focus on neurodegenerative, inflammatory, and infectious diseases, ARIScience employs cutting-edge in silico methods to efficiently identify and optimize drug candidates. Their commitment to innovation and collaboration with leading institutions positions them to make a significant impact on human health. ARIScience is creating value in two ways: Value 1: ARIScience is developing small molecule assets targeting respiratory depression, cutaneous burn and radiation injuries, antivirals for EBOV and DENV, bacteriostatic antibiotic targeting Staph aureus. Value 2: It's novel AI driven quasi quantum chemistry (AI+QQ) small molecule discovery platform for precision protein inhibition and potentiation.

X-trodes is a pioneering company in wearable electrophysiological monitoring, dedicated to liberating data collection from traditional lab settings. Their mission is to enhance healthcare quality, accessibility, and efficiency by enabling real-life, medical-grade monitoring through innovative, flexible skin patches and advanced sensor technology. Rooted in over a decade of research at Prof. Yael Hanein’s Neuro Engineering laboratory, X-trodes empowers healthcare practitioners, patients, and researchers with actionable insights, personalized treatments, and improved outcomes. Their technology is validated by extensive scientific research and is designed for use in diverse environments, making healthcare more inclusive and accessible for all. X-trodes emphasizes collaboration with industry leaders and research centers, user-friendly design for self-application, and the development of robust data analysis algorithms to ensure high-quality, actionable data in real-world settings.

UT Southwestern Medical Center is a premier academic medical institution dedicated to advancing medical science and improving health care through excellence in education, research, and patient care. The center is renowned for its collaborative environment that fosters innovation and discovery, housing distinguished faculty including Nobel Laureates. UT Southwestern is recognized for its groundbreaking research, comprehensive educational programs, and commitment to patient care, serving millions annually across its facilities.

Inertia is an innovation-driven firm delivering end-to-end design, engineering, prototyping, and manufacturing for medical, clean tech, industrial, safety, and advanced hardware industries. Distinguished by their tightly integrated evidence-based approach—including strategy, human factors, regulatory and advanced manufacturing—they execute at every phase: from early startup product validation through SMB innovation acceleration, to full-scale manufacturing for startup and large enterprises. Their unique differentiator lies in the seamless integration of product strategy, development, and manufacturing under one roof—enabling clients to optimize quality, achieve rapid speed-to-market, and realize measurable cost and risk reductions. With robust quality systems, client-centered project management, and a reputation for transparency, Inertia consistently sets new standards for product innovation and commercialization.

UConn Health is a vibrant, integrated academic medical center that is entering an era of unprecedented growth in academics, research, and clinical care. The campus hosts the Schools of Medicine and Dental Medicine with their respective graduate research programs, medical and dental clinics, and the UConn John Dempsey Hospital, rated as one of the World’s Best Hospitals for Infection Prevention and Patient Experience, and one of America’s Best-in-State Hospitals by Newsweek for the past four years. Recent investments in infrastructure, including new construction and renovated laboratory and teaching spaces, demonstrate a commitment to providing our faculty with access to the best possible infrastructure for scientific discovery, supporting Connecticut's and our region's need for innovation in service of our patients, transformative research, and society. We empower faculty, students, and industry partners to advance solutions that benefit Connecticut and the world, driving innovation, discovery, and societal impact through robust partnerships, state-of-the-art facilities, and a collaborative environment.

Stanford University, founded nearly 150 years ago, is dedicated to educating students for lives of leadership and contribution with integrity. The university emphasizes advancing fundamental knowledge, cultivating creativity, and pioneering research for effective clinical therapies, while also focusing on societal impact and solutions.

The Geneva Foundation is a 501(c)3 nonprofit established in 1993, dedicated to advancing military medicine through research, development, and education. With a commitment to ensuring optimal health for service members and the communities they serve, Geneva collaborates with various partners to drive innovative medical research and improve healthcare outcomes.

Pinetics is a leader in product design and development, specializing in delivering agile, manufacturing-ready solutions for clients worldwide. With over 18 years of industry experience, Pinetics offers expertise across the entire product development lifecycle, including electronics hardware, firmware, embedded operating systems, IoT, IoMT, and industrial design. The company serves diverse sectors such as Medtech, Industrial Automation, Defence, and Automotive & EV, helping clients transform bold ideas into impactful realities through end-to-end development, prototyping, and regulatory compliance.

Halite Medical is building the secure, interoperable AI infrastructure that transforms emergency and battlefield medicine. Our platform ensures that critical patient data flows securely and continuously from the point of injury through every stage of care, enabling predictive, life-saving decisions in the most time-sensitive environments.

MitoSense, Inc. is a research and development company focused on developing treatments for neurodegenerative diseases through innovative mitochondrial therapies. With exclusive licensing of Mitochondria Organelle Transplantation (MOT™) technology, MitoSense aims to improve the lives of patients suffering from conditions such as ALS, Alzheimer's, and Parkinson's disease.

Tensentric is a contract design and manufacturing firm focused solely on medical device, in vitro diagnostic, and advanced therapy markets. We're ISO13485 certified and FDA registered to help our clients bring their new technology and products to market.

SPOC Biosciences is a life sciences technology company focused on advancing proteomics through high-plex biosensor chip platforms. The company enables high-throughput, cost-effective protein production and deep characterization of protein interactions using techniques such as cell-free expression and multiplexed SPR biosensing. Their platform accelerates drug discovery, AI-driven drug design, biomarker identification, diagnostics, antibody screening, and vaccine development by generating scalable, high-resolution kinetic datasets suitable for advanced analytics and AI model training.

Columbia University is a leading Ivy League research university in New York City, founded in 1754. It comprises undergraduate and graduate programs across 17+ schools, a world-renowned medical center, nearly 200 research centers and institutes, and extensive campus-life and student-services resources. Columbia supports broad disciplinary research (examples in the new content: extensive faculty-hosted publications and CVs such as those for Dustin R. Rubenstein), interdisciplinary initiatives (Columbia Climate School, Columbia Global Centers), and public events, conferences and workshops. Faculty labs and departmental pages host teaching and research materials (lecture notes, method papers, and open-access PDFs). Columbia also preserves and documents its technological and computing heritage: the IBM 650 Magnetic Drum Data Processing Machine was the first general-purpose computer installed and used at Columbia (Watson Scientific Computing Laboratory, installed beginning August 1955), and important early software work (e.g., the SOAP assembler) and intensive computing courses were developed and taught on these machines. Recent leadership transitions and active public programming continue alongside ongoing research expansion and global engagement. (Overview synthesized from Columbia University pages, faculty-hosted materials, and the Columbia Computing History archive.)

Scissortail Therapeutics is a biopharmaceutical company focused on developing precision biologics for musculoskeletal injuries and osteoarthritis. The company emphasizes innovative, targeted therapeutics that aim to address the underlying mechanisms of joint disease, collaborating with diverse stakeholders such as academic institutions and clinicians to advance joint protection and regeneration. Scientific rigor, patient-centricity, innovation, and collaboration are central values supporting its mission to create transformative therapies.

The Icahn School of Medicine at Mount Sinai, located in New York City, is an international leader in biomedical education, research, and patient care. As the academic partner of the Mount Sinai Health System, the school is renowned for its innovative education, groundbreaking research, and commitment to health equity. With over 7,000 faculty, 1,200 students, and 2,500 residents and fellows, the institution fosters a culture of bold thinking, multidisciplinary teamwork, and a willingness to challenge conventional wisdom. Its mission is to radically advance the art and science of medical care through collaborative learning, scholarly inquiry, and a deep respect for diversity, preparing the next generation of healthcare leaders to revolutionize medicine and biomedical science.

Zymeron is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative healthcare technologies that deliver step-change performance. The company focuses on proactive health solutions to address critical unmet needs in the pharmaceutical sciences, particularly in drug delivery and formulation technologies.

Tir Medical develops pre-hospital medical devices focused on limb immobilization and localized thermal therapy for emergency care providers. The company leverages expertise in trauma medicine, military medicine, and engineering, and collaborates with leading institutions to address critical needs in pre-hospital trauma care.

CuriRx is a minority woman-owned Contract Research, Development, and Manufacturing Organization (CRDMO) based in Massachusetts. The company provides comprehensive solutions for drug development with expertise in bioprocessing, formulation development, analytical testing, and manufacturing support. CuriRx offers services across the therapeutic development spectrum, including customized solutions, collaboration, cutting-edge analytical methods, and process optimization to accelerate client projects from discovery to clinical and commercial stages.

Signature Science, LLC is a multidisciplinary applied science and technology company dedicated to solving the toughest forensic, biosecurity, and public health challenges. Serving both government and commercial clients, Signature Science combines scientific rigor with proven quality assurance to enhance the credibility and defensibility of programs in national security, public safety, and health security. The company is recognized for its innovation, technical excellence, and commitment to advancing the state-of-the-art in forensic science, genomics, and biosecurity technologies. Signature Science also offers advanced bioinformatics and microbiome analysis services, empowering clients with data-driven insights to address emerging threats, pandemics, and bioterrorism. The company is a subsidiary of Southwest Research Institute and is committed to community engagement and workforce development.

Dasion is a healthcare technology company pioneering the use of advanced machine learning and artificial intelligence to deliver fast, explainable clinical decision support. Their mission is to empower healthcare organizations and professionals to leverage their proprietary Geometric Unified Learning (GUL) technology for improved diagnostics, treatment planning, and patient care. Dasion's solutions focus on enhancing healthcare outcomes and quality of life for all ages by providing real-time, predictive analytics and actionable insights from diverse data sources, including voice and medical imaging.

PDV MedTech, previously known as Phoenix DeVentures, is a U.S.-based company founded in 2001 specializing in medical device design, development, and ISO 13485:2016-certified contract manufacturing. Acquired by INDO-MIM in 2025, the company offers end-to-end solutions from prototyping to high-volume production with capabilities in injection molding, 3D printing, fabrication of mold tools, and cleanroom assembly. PDV MedTech supports startups and innovators in commercializing their devices through regulatory support, quality management, and scalable manufacturing across locations in California, Colorado, and Utah.

Thendor Therapeutics is an early-stage biotechnology company focused on developing therapies aimed at reversing, halting, and preventing fibrosis across multiple organ systems. Leveraging peptide-based drug discovery, the company's mission is to restore tissue function and improve patient outcomes in pulmonary, urological, and systemic fibrotic diseases. Through a combination of targeted pathway research, regenerative approaches, and platform innovation, Thendor Therapeutics seeks to address unmet needs in fibrotic disease, which currently lacks effective treatments.

The Texas A&M Engineering Experiment Station (TEES) is a state agency and part of the Texas A&M University System, dedicated to improving lives through engineering research, workforce development, and technology transition. TEES collaborates with industry, academia, and government to provide innovative solutions to global technical challenges.